{
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Rosemary D.",
                    "initial": "R.D.",
                    "last": "Higgins"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Saade"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Polin"
                },
                {
                    "first": "William A.",
                    "initial": "W.A.",
                    "last": "Grobman"
                },
                {
                    "first": "Irina A.",
                    "initial": "I.A.",
                    "last": "Buhimschi"
                },
                {
                    "first": "Kristi",
                    "initial": "K.",
                    "last": "Watterberg"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Silver"
                },
                {
                    "first": "Tonse N.K.",
                    "initial": "T.N.K.",
                    "last": "Raju"
                }
            ],
            "doi": "10.1097/AOG.0000000000001246",
            "firstpage": "426",
            "issn": "00297844",
            "lastpage": "436",
            "pmid": "26855098",
            "pub_year": 2016,
            "title": "Evaluation and Management of Women and Newborns with a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop",
            "volume": "127"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Alan T.N.",
                    "initial": "A.T.N.",
                    "last": "Tita"
                },
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Andrews"
                }
            ],
            "doi": "10.1016/j.clp.2010.02.003",
            "firstpage": "339",
            "issn": "00955108",
            "lastpage": "354",
            "pmid": "20569811",
            "pub_year": 2010,
            "title": "Diagnosis and management of clinical chorioamnionitis",
            "volume": "37"
        },
        "b0015": {
            "authors": [
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Ogunyemi"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Murillo"
                },
                {
                    "first": "U.",
                    "initial": "U.",
                    "last": "Jackson"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Hunter"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Alperson"
                }
            ],
            "doi": "10.1080/jmf.13.2.102.109",
            "firstpage": "102",
            "issn": "14767058",
            "lastpage": "109",
            "pmid": "12735410",
            "pub_year": 2003,
            "title": "The relationship between placental histopathology findings and perinatal outcome in preterm infants",
            "volume": "13"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Ronald S.",
                    "initial": "R.S.",
                    "last": "Gibbs"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Duff"
                }
            ],
            "doi": "10.1016/0002-9378(91)90707-X",
            "firstpage": "1317",
            "issn": "00029378",
            "lastpage": "1326",
            "pmid": "2035575",
            "pub_year": 1991,
            "title": "Progress in pathogenesis and management of clinical intraamniotic infection",
            "volume": "164"
        },
        "b0025": {
            "authors": [
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Soper"
                },
                {
                    "first": "C. Glen",
                    "initial": "C.G.",
                    "last": "Mayhall"
                },
                {
                    "first": "Harry P.",
                    "initial": "H.P.",
                    "last": "Dalton"
                }
            ],
            "doi": "10.1016/0002-9378(89)90356-6",
            "firstpage": "562",
            "issn": "00029378",
            "lastpage": "568",
            "pmid": "2782335",
            "pub_year": 1989,
            "title": "Risk factors for intraamniotic infection: A prospective epidemiologic study",
            "volume": "161"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Bo Hyun",
                    "initial": "B.H.",
                    "last": "Yoon"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Romero"
                },
                {
                    "first": "Jeong Bin",
                    "initial": "J.B.",
                    "last": "Moon"
                },
                {
                    "first": "Soon Sup",
                    "initial": "S.S.",
                    "last": "Shim"
                },
                {
                    "first": "Miha",
                    "initial": "M.",
                    "last": "Kim"
                },
                {
                    "first": "Gilja",
                    "initial": "G.",
                    "last": "Kim"
                },
                {
                    "first": "Jong Kwan",
                    "initial": "J.K.",
                    "last": "Jun"
                }
            ],
            "doi": "10.1067/mob.2001.117680",
            "firstpage": "1130",
            "issn": "00029378",
            "lastpage": "1136",
            "pub_year": 2001,
            "title": "Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes",
            "volume": "185"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Robert L.",
                    "initial": "R.L.",
                    "last": "Goldenberg"
                },
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Andrews"
                },
                {
                    "first": "John C.",
                    "initial": "J.C.",
                    "last": "Hauth"
                }
            ],
            "firstpage": "S19",
            "issn": "00296643",
            "lastpage": "S25",
            "pmid": "12035853",
            "pub_year": 2002,
            "title": "Choriodecidual infection and preterm birth",
            "volume": "60"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Hyo Suk",
                    "initial": "H.S.",
                    "last": "Seong"
                },
                {
                    "first": "Si Eun",
                    "initial": "S.E.",
                    "last": "Lee"
                },
                {
                    "first": "Ji Hyun",
                    "initial": "J.H.",
                    "last": "Kang"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Romero"
                },
                {
                    "first": "Bo Hyun",
                    "initial": "B.H.",
                    "last": "Yoon"
                }
            ],
            "doi": "10.1016/j.ajog.2008.06.040",
            "firstpage": "375",
            "issn": "00029378",
            "lastpage": "375.e5",
            "pmid": "18928978",
            "pub_year": 2008,
            "title": "The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor",
            "volume": "199"
        },
        "b0045": {
            "authors": [
                {
                    "first": "P. G.",
                    "initial": "P.G.",
                    "last": "Seaward"
                },
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Hannah"
                },
                {
                    "first": "T. L.",
                    "initial": "T.L.",
                    "last": "Myhr"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Farine"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ohlsson"
                },
                {
                    "first": "E. E.",
                    "initial": "E.E.",
                    "last": "Wang"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Haque"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Weston"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "Hewson"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Ohel"
                },
                {
                    "first": "E. D.",
                    "initial": "E.D.",
                    "last": "Hodnett"
                }
            ],
            "doi": "10.1016/S0002-9378(97)70007-3",
            "firstpage": "1024",
            "issn": "00029378",
            "lastpage": "1029",
            "pmid": "9396886",
            "pub_year": 1997,
            "title": "International multicentre term prelabor rupture of membranes study: Evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term",
            "volume": "177"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Vaughn I.",
                    "initial": "V.I.",
                    "last": "Rickert"
                },
                {
                    "first": "Constance M.",
                    "initial": "C.M.",
                    "last": "Wiemann"
                },
                {
                    "first": "Gary D.V.",
                    "initial": "G.D.V.",
                    "last": "Hankins"
                },
                {
                    "first": "Juliet M.",
                    "initial": "J.M.",
                    "last": "McKee"
                },
                {
                    "first": "Abbey B.",
                    "initial": "A.B.",
                    "last": "Berenson"
                }
            ],
            "doi": "10.1016/S0029-7844(98)00135-5",
            "firstpage": "254",
            "issn": "00297844",
            "lastpage": "257",
            "pmid": "9699762",
            "pub_year": 1998,
            "title": "Prevalence and risk factors of chorioamnionitis among adolescents",
            "volume": "92"
        },
        "b0055": {
            "authors": [
                {
                    "first": "E. R.",
                    "initial": "E.R.",
                    "last": "Newton"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Piper"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Peairs"
                }
            ],
            "doi": "10.1016/S0002-9378(97)70568-4",
            "firstpage": "672",
            "issn": "00029378",
            "lastpage": "677",
            "pmid": "9077627",
            "pub_year": 1997,
            "title": "Bacterial vaginosis and intraamniotic infection",
            "volume": "176"
        },
        "b0060": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Abele-Horn"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Peters"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Genzel-Borovicz\u00e9ny"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Wolff"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Zimmermann"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Gottschling"
                }
            ],
            "doi": "10.1007/BF01720398",
            "firstpage": "286",
            "issn": "03008126",
            "lastpage": "291",
            "pmid": "9334863",
            "pub_year": 1997,
            "title": "Vaginal Ureaplasma urealyticum colonization: Influence on pregnancy outcome and neonatal morbidity",
            "volume": "25"
        },
        "b0065": {
            "authors": [
                {
                    "first": "SARAH P.",
                    "initial": "S.P.",
                    "last": "MARK"
                },
                {
                    "first": "MARY S.",
                    "initial": "M.S.",
                    "last": "CROUGHAN-MINIHANE"
                },
                {
                    "first": "SARAH J.",
                    "initial": "S.J.",
                    "last": "KILPATRICK"
                }
            ],
            "firstpage": "909",
            "issn": "00297844",
            "lastpage": "912",
            "pmid": "10831982",
            "pub_year": 2000,
            "title": "Chorioamnionitis and uterine function",
            "volume": "95"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Dwight J.",
                    "initial": "D.J.",
                    "last": "Rouse"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Landon"
                },
                {
                    "first": "Kenneth J.",
                    "initial": "K.J.",
                    "last": "Leveno"
                },
                {
                    "first": "Sharon",
                    "initial": "S.",
                    "last": "Leindecker"
                },
                {
                    "first": "Michael W.",
                    "initial": "M.W.",
                    "last": "Varner"
                },
                {
                    "first": "Steve N.",
                    "initial": "S.N.",
                    "last": "Caritis"
                },
                {
                    "first": "Mary Jo",
                    "initial": "M.J.",
                    "last": "O'Sullivan"
                },
                {
                    "first": "Ronald J.",
                    "initial": "R.J.",
                    "last": "Wapner"
                },
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Meis"
                },
                {
                    "first": "Menachem",
                    "initial": "M.",
                    "last": "Miodovnik"
                },
                {
                    "first": "Yoram",
                    "initial": "Y.",
                    "last": "Sorokin"
                },
                {
                    "first": "Atef H.",
                    "initial": "A.H.",
                    "last": "Moawad"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Mabie"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Conway"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Gabbe"
                },
                {
                    "first": "Catherine Y.",
                    "initial": "C.Y.",
                    "last": "Spong"
                }
            ],
            "doi": "10.1016/j.ajog.2004.03.003",
            "firstpage": "211",
            "issn": "00029378",
            "lastpage": "216",
            "pmid": "15295368",
            "pub_year": 2004,
            "title": "The maternal-fetal medicine units cesarean registry: Chorioamnionitis at term and its duration - Relationship to outcomes",
            "volume": "191"
        },
        "b0075": {
            "authors": [
                {
                    "first": "W. J.",
                    "initial": "W.J.",
                    "last": "Morales"
                },
                {
                    "first": "S. R.",
                    "initial": "S.R.",
                    "last": "Washington"
                },
                {
                    "first": "A. J.",
                    "initial": "A.J.",
                    "last": "Lazar"
                }
            ],
            "firstpage": "105",
            "issn": "07438346",
            "lastpage": "110",
            "pmid": "3505603",
            "pub_year": 1987,
            "title": "The effect of chorioamnionitis on perinatal outcome in preterm gestation.",
            "volume": "7"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Lale",
                    "initial": "L.",
                    "last": "Say"
                },
                {
                    "first": "Doris",
                    "initial": "D.",
                    "last": "Chou"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Gemmill"
                },
                {
                    "first": "\u00d6zge",
                    "initial": "O.",
                    "last": "Tun\u00e7alp"
                },
                {
                    "first": "Ann Beth",
                    "initial": "A.B.",
                    "last": "Moller"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Daniels"
                },
                {
                    "first": "A. Metin",
                    "initial": "A.M.",
                    "last": "G\u00fclmezoglu"
                },
                {
                    "first": "Marleen",
                    "initial": "M.",
                    "last": "Temmerman"
                },
                {
                    "first": "Leontine",
                    "initial": "L.",
                    "last": "Alkema"
                }
            ],
            "doi": "10.1016/S2214-109X(14)70227-X",
            "firstpage": "e323",
            "issn": "2214109X",
            "lastpage": "e333",
            "pmid": "25103301",
            "pub_year": 2014,
            "title": "Global causes of maternal death: A WHO systematic analysis",
            "volume": "2"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Jeroen",
                    "initial": "J.",
                    "last": "Van Dillen"
                },
                {
                    "first": "Joost",
                    "initial": "J.",
                    "last": "Zwart"
                },
                {
                    "first": "Joke",
                    "initial": "J.",
                    "last": "Schutte"
                },
                {
                    "first": "Jos",
                    "initial": "J.",
                    "last": "Van Roosmalen"
                }
            ],
            "doi": "10.1097/QCO.0b013e328339257c",
            "firstpage": "249",
            "issn": "09517375",
            "lastpage": "254",
            "pmid": "20375891",
            "pub_year": 2010,
            "title": "Maternal sepsis: Epidemiology, etiology and outcome",
            "volume": "23"
        },
        "b0090": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Pacora"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Chaiworapongsa"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Maymon"
                },
                {
                    "first": "Y. M.",
                    "initial": "Y.M.",
                    "last": "Kim"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Gomez"
                },
                {
                    "first": "B. H.",
                    "initial": "B.H.",
                    "last": "Yoon"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Ghezzi"
                },
                {
                    "first": "S. M.",
                    "initial": "S.M.",
                    "last": "Berry"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Qureshi"
                },
                {
                    "first": "S. M.",
                    "initial": "S.M.",
                    "last": "Jacques"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Kim"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Kadar"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Romero"
                }
            ],
            "firstpage": "18",
            "issn": "10570802",
            "lastpage": "25",
            "pmid": "12380603",
            "pub_year": 2002,
            "title": "Funisitis and chorionic vasculitis: The histological counterpart of the fetal inflammatory response syndrome",
            "volume": "11"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Bo Hyun",
                    "initial": "B.H.",
                    "last": "Yoon"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Romero"
                },
                {
                    "first": "Kyung Sun",
                    "initial": "K.S.",
                    "last": "Kim"
                },
                {
                    "first": "Joong Shin",
                    "initial": "J.S.",
                    "last": "Park"
                },
                {
                    "first": "Suk Hyun",
                    "initial": "S.H.",
                    "last": "Ki"
                },
                {
                    "first": "Beyong",
                    "initial": "B.",
                    "last": "Kim"
                },
                {
                    "first": "Jong Kwan",
                    "initial": "J.K.",
                    "last": "Jun"
                }
            ],
            "doi": "10.1016/S0002-9378(99)70299-1",
            "firstpage": "773",
            "issn": "00029378",
            "lastpage": "779",
            "pmid": "10521727",
            "pub_year": 1999,
            "title": "A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia",
            "volume": "181"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Asher",
                    "initial": "A.",
                    "last": "Bashiri"
                },
                {
                    "first": "Eliezer",
                    "initial": "E.",
                    "last": "Burstein"
                },
                {
                    "first": "Moshe",
                    "initial": "M.",
                    "last": "Mazor"
                }
            ],
            "doi": "10.1515/JPM.2006.001",
            "firstpage": "5",
            "issn": "03005577",
            "lastpage": "12",
            "pmid": "16489880",
            "pub_year": 2006,
            "title": "Cerebral palsy and fetal inflammatory response syndrome: A review",
            "volume": "34"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Hassan"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Romero"
                },
                {
                    "first": "Israel",
                    "initial": "I.",
                    "last": "Hendler"
                },
                {
                    "first": "Ricardo",
                    "initial": "R.",
                    "last": "Gomez"
                },
                {
                    "first": "Nahla",
                    "initial": "N.",
                    "last": "Khalek"
                },
                {
                    "first": "Jimmy",
                    "initial": "J.",
                    "last": "Espinoza"
                },
                {
                    "first": "Kae Nien",
                    "initial": "K.N.",
                    "last": "Jyh"
                },
                {
                    "first": "Stanley M.",
                    "initial": "S.M.",
                    "last": "Berry"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Bujold"
                },
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Camacho"
                },
                {
                    "first": "Yoram",
                    "initial": "Y.",
                    "last": "Sorokin"
                }
            ],
            "doi": "10.1515/JPM.2006.002",
            "firstpage": "13",
            "issn": "03005577",
            "lastpage": "19",
            "pmid": "16489881",
            "pub_year": 2006,
            "title": "A sonographic short cervix as the only clinical manifestation of intra-amniotic infection",
            "volume": "34"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Marijane A.",
                    "initial": "M.A.",
                    "last": "Krohn"
                },
                {
                    "first": "Sharon L.",
                    "initial": "S.L.",
                    "last": "Hillier"
                },
                {
                    "first": "Nancy B.",
                    "initial": "N.B.",
                    "last": "Kiviat"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Eschenbach"
                }
            ],
            "doi": "10.1016/1047-2797(93)90013-T",
            "firstpage": "78",
            "issn": "10472797",
            "lastpage": "85",
            "pmid": "8287160",
            "pub_year": 1993,
            "title": "The severity of fetal membrane infection and pregnancy complications",
            "volume": "3"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Ylze",
                    "initial": "Y.",
                    "last": "Dong"
                },
                {
                    "first": "Patrzcza J.St",
                    "initial": "P.J.S.",
                    "last": "Clazr"
                },
                {
                    "first": "Zbrahzm",
                    "initial": "Z.",
                    "last": "Ramzy"
                },
                {
                    "first": "Kathleen S.",
                    "initial": "K.S.",
                    "last": "Kagan-Hallet"
                },
                {
                    "first": "Ronald S.",
                    "initial": "R.S.",
                    "last": "Gibbs"
                }
            ],
            "firstpage": "175",
            "issn": "00297844",
            "lastpage": "182",
            "pmid": "3601279",
            "pub_year": 1987,
            "title": "A microbiologic and clinical study of placental inflammation at term",
            "volume": "70"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Carolyn M.",
                    "initial": "C.M.",
                    "last": "Salafia"
                },
                {
                    "first": "Cristine",
                    "initial": "C.",
                    "last": "Weigl"
                },
                {
                    "first": "Lester",
                    "initial": "L.",
                    "last": "Silberman"
                }
            ],
            "firstpage": "383",
            "issn": "00297844",
            "lastpage": "389",
            "pmid": "2915862",
            "pub_year": 1989,
            "title": "The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies",
            "volume": "73"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Ronald S.",
                    "initial": "R.S.",
                    "last": "Gibbs"
                },
                {
                    "first": "Jorge D.",
                    "initial": "J.D.",
                    "last": "Blanco"
                },
                {
                    "first": "Patricia J.",
                    "initial": "P.J.",
                    "last": "St Clair"
                },
                {
                    "first": "Yolanda S.",
                    "initial": "Y.S.",
                    "last": "Castaneda"
                }
            ],
            "doi": "10.1093/infdis/145.1.1",
            "firstpage": "1",
            "issn": "00221899",
            "lastpage": "8",
            "pmid": "7033397",
            "pub_year": 1982,
            "title": "Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term",
            "volume": "145"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Drucilla J.",
                    "initial": "D.J.",
                    "last": "Roberts"
                },
                {
                    "first": "Ann C.",
                    "initial": "A.C.",
                    "last": "Celi"
                },
                {
                    "first": "Laura E.",
                    "initial": "L.E.",
                    "last": "Riley"
                },
                {
                    "first": "Andrew B.",
                    "initial": "A.B.",
                    "last": "Onderdonk"
                },
                {
                    "first": "Theonia K.",
                    "initial": "T.K.",
                    "last": "Boyd"
                },
                {
                    "first": "Lise Carolyn",
                    "initial": "L.C.",
                    "last": "Johnson"
                },
                {
                    "first": "Ellice",
                    "initial": "E.",
                    "last": "Lieberman"
                }
            ],
            "doi": "10.1371/journal.pone.0031819",
            "issn": "19326203",
            "pmid": "22412842",
            "pub_year": 2012,
            "title": "Acute histologic chorioamnionitis at term: Nearly always noninfectious",
            "volume": "7"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Chong Jai",
                    "initial": "C.J.",
                    "last": "Kim"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Romero"
                },
                {
                    "first": "Piya",
                    "initial": "P.",
                    "last": "Chaemsaithong"
                },
                {
                    "first": "Noppadol",
                    "initial": "N.",
                    "last": "Chaiyasit"
                },
                {
                    "first": "Bo Hyun",
                    "initial": "B.H.",
                    "last": "Yoon"
                },
                {
                    "first": "Yeon Mee",
                    "initial": "Y.M.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1016/j.ajog.2015.08.040",
            "firstpage": "S29",
            "issn": "00029378",
            "lastpage": "S52",
            "pmid": "26428501",
            "pub_year": 2015,
            "title": "Acute chorioamnionitis and funisitis: Definition, pathologic features, and clinical significance",
            "volume": "213"
        },
        "b0140": null,
        "b0145": null,
        "b0150": null,
        "b0155": null,
        "b0160": {
            "authors": [
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1097/AOG.0000000000002236",
            "firstpage": "e95",
            "issn": "1873233X",
            "lastpage": "e101",
            "pmid": "28742677",
            "pub_year": 2017,
            "title": "Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection",
            "volume": "130"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "McMillan"
                },
                {
                    "first": "Michelle",
                    "initial": "M.",
                    "last": "Clarke"
                },
                {
                    "first": "Adriana",
                    "initial": "A.",
                    "last": "Parrella"
                },
                {
                    "first": "Deshayne B.",
                    "initial": "D.B.",
                    "last": "Fell"
                },
                {
                    "first": "Gayatri",
                    "initial": "G.",
                    "last": "Amirthalingam"
                },
                {
                    "first": "Helen S.",
                    "initial": "H.S.",
                    "last": "Marshall"
                }
            ],
            "doi": "10.1097/AOG.0000000000001888",
            "firstpage": "560",
            "issn": "00297844",
            "lastpage": "573",
            "pmid": "28178054",
            "pub_year": 2017,
            "title": "Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy a systematic review",
            "volume": "129"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Elyse O.",
                    "initial": "E.O.",
                    "last": "Kharbanda"
                },
                {
                    "first": "Gabriela",
                    "initial": "G.",
                    "last": "Vazquez-Benitez"
                },
                {
                    "first": "Heather S.",
                    "initial": "H.S.",
                    "last": "Lipkind"
                },
                {
                    "first": "Nicola P.",
                    "initial": "N.P.",
                    "last": "Klein"
                },
                {
                    "first": "T. Craig",
                    "initial": "T.C.",
                    "last": "Cheetham"
                },
                {
                    "first": "Allison",
                    "initial": "A.",
                    "last": "Naleway"
                },
                {
                    "first": "Saad B.",
                    "initial": "S.B.",
                    "last": "Omer"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Hambidge"
                },
                {
                    "first": "Grace M.",
                    "initial": "G.M.",
                    "last": "Lee"
                },
                {
                    "first": "Michael L.",
                    "initial": "M.L.",
                    "last": "Jackson"
                },
                {
                    "first": "Natalie L.",
                    "initial": "N.L.",
                    "last": "McCarthy"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "DeStefano"
                },
                {
                    "first": "James D.",
                    "initial": "J.D.",
                    "last": "Nordin"
                }
            ],
            "doi": "10.1001/jama.2014.14825",
            "firstpage": "1897",
            "issn": "00987484",
            "lastpage": "1904",
            "pmid": "25387187",
            "pub_year": 2014,
            "title": "Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes",
            "volume": "312"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Jamie L.",
                    "initial": "J.L.",
                    "last": "Morgan"
                },
                {
                    "first": "Sangameshwar R.",
                    "initial": "S.R.",
                    "last": "Baggari"
                },
                {
                    "first": "Donald D.",
                    "initial": "D.D.",
                    "last": "McIntire"
                },
                {
                    "first": "Jeanne S.",
                    "initial": "J.S.",
                    "last": "Sheffield"
                }
            ],
            "doi": "10.1097/AOG.0000000000000862",
            "firstpage": "1433",
            "issn": "00297844",
            "lastpage": "1438",
            "pmid": "26000515",
            "pub_year": 2015,
            "title": "Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination",
            "volume": "125"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Abbey B.",
                    "initial": "A.B.",
                    "last": "Berenson"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Hirth"
                },
                {
                    "first": "Mahbubur",
                    "initial": "M.",
                    "last": "Rahman"
                },
                {
                    "first": "Tabassum H.",
                    "initial": "T.H.",
                    "last": "Laz"
                },
                {
                    "first": "Richard E.",
                    "initial": "R.E.",
                    "last": "Rupp"
                },
                {
                    "first": "Kwabena O.",
                    "initial": "K.O.",
                    "last": "Sarpong"
                }
            ],
            "doi": "10.1080/21645515.2016.1157241",
            "firstpage": "1965",
            "issn": "21645515",
            "lastpage": "1971",
            "pmid": "27002930",
            "pub_year": 2016,
            "title": "Maternal and infant outcomes among women vaccinated against pertussis during pregnancy",
            "volume": "12"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Hema",
                    "initial": "H.",
                    "last": "Datwani"
                },
                {
                    "first": "Pedro L.",
                    "initial": "P.L.",
                    "last": "Moro"
                },
                {
                    "first": "Theresa",
                    "initial": "T.",
                    "last": "Harrington"
                },
                {
                    "first": "Karen R.",
                    "initial": "K.R.",
                    "last": "Broder"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.04.097",
            "firstpage": "3110",
            "issn": "0264410X",
            "lastpage": "3113",
            "pmid": "25976546",
            "pub_year": 2015,
            "title": "Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System",
            "volume": "33"
        },
        "b0190": null,
        "b0195": null,
        "b0200": null,
        "b0205": null,
        "b0210": {
            "authors": [
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Bonhoeffer"
                },
                {
                    "first": "Sonali",
                    "initial": "S.",
                    "last": "Kochhar"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Hirschfeld"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Heath"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Jones"
                },
                {
                    "first": "Jorgen",
                    "initial": "J.",
                    "last": "Bauwens"
                },
                {
                    "first": "\u00c1ngel",
                    "initial": "\u00c1.",
                    "last": "Honrado"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Heininger"
                },
                {
                    "first": "Flor M.",
                    "initial": "F.M.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Eckert"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Steinhoff"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Black"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Padula"
                },
                {
                    "first": "Miriam",
                    "initial": "M.",
                    "last": "Sturkenboom"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Buttery"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Pless"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Zuber"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2016.07.006",
            "firstpage": "5993",
            "issn": "0264410X",
            "lastpage": "5997",
            "pmid": "27751641",
            "pub_year": 2016,
            "title": "Global alignment of immunization safety assessment in pregnancy \u2013 The GAIA project",
            "volume": "34"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Jodi S.",
                    "initial": "J.S.",
                    "last": "Dashe"
                },
                {
                    "first": "Beverly B.",
                    "initial": "B.B.",
                    "last": "Rogers"
                },
                {
                    "first": "Donald D.",
                    "initial": "D.D.",
                    "last": "Mcintire"
                },
                {
                    "first": "Kenneth J.",
                    "initial": "K.J.",
                    "last": "Leveno"
                }
            ],
            "doi": "10.1016/S0029-7844(98)00415-3",
            "firstpage": "341",
            "issn": "00297844",
            "lastpage": "344",
            "pmid": "10074975",
            "pub_year": 1999,
            "title": "Epidural analgesia and intrapartum fever: Placental findings",
            "volume": "93"
        },
        "b0220": {
            "authors": [
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Apantaku"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Mulik"
                }
            ],
            "doi": "10.1080/01443610601016644",
            "firstpage": "12",
            "issn": "01443615",
            "lastpage": "15",
            "pmid": "17365450",
            "pub_year": 2007,
            "title": "Maternal intra-partum fever",
            "volume": "27"
        },
        "b0225": {
            "authors": [
                {
                    "first": "E. R.",
                    "initial": "E.R.",
                    "last": "Newton"
                }
            ],
            "doi": "10.1097/00003081-199312000-00004",
            "firstpage": "795",
            "issn": "00099201",
            "lastpage": "808",
            "pmid": "8293582",
            "pub_year": 1993,
            "title": "Chorioamnionitis and intraamniotic infection",
            "volume": "36"
        },
        "b0230": {
            "authors": [
                {
                    "first": "S. Michael",
                    "initial": "S.M.",
                    "last": "Marcy"
                },
                {
                    "first": "Katrin S.",
                    "initial": "K.S.",
                    "last": "Kohl"
                },
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Nalin"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Blum"
                },
                {
                    "first": "Marcy Connell",
                    "initial": "M.C.",
                    "last": "Jones"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Hansen"
                },
                {
                    "first": "Jerry",
                    "initial": "J.",
                    "last": "Labadie"
                },
                {
                    "first": "Lucia",
                    "initial": "L.",
                    "last": "Lee"
                },
                {
                    "first": "Bryan L.",
                    "initial": "B.L.",
                    "last": "Martin"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "O'Brien"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Rothstein"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Vermeer"
                }
            ],
            "doi": "10.1016/j.vaccine.2003.09.007",
            "firstpage": "551",
            "issn": "0264410X",
            "lastpage": "556",
            "pmid": "14741143",
            "pub_year": 2004,
            "title": "Fever as an adverse event following immunization: Case definition and guidelines of data collection, analysis, and presentation",
            "volume": "22"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Kazuhisa",
                    "initial": "K.",
                    "last": "Maeda"
                },
                {
                    "first": "Noboru",
                    "initial": "N.",
                    "last": "Matsuzaki"
                },
                {
                    "first": "Shinji",
                    "initial": "S.",
                    "last": "Fuke"
                },
                {
                    "first": "Nobuaki",
                    "initial": "N.",
                    "last": "Mitsuda"
                },
                {
                    "first": "Koichiro",
                    "initial": "K.",
                    "last": "Shimoya"
                },
                {
                    "first": "Masahiro",
                    "initial": "M.",
                    "last": "Nakayama"
                },
                {
                    "first": "Noriyuki",
                    "initial": "N.",
                    "last": "Suehara"
                },
                {
                    "first": "Toshihiro",
                    "initial": "T.",
                    "last": "Aono"
                }
            ],
            "doi": "10.1159/000291862",
            "firstpage": "225",
            "issn": "03787346",
            "lastpage": "231",
            "pmid": "9194619",
            "pub_year": 1997,
            "title": "Value of the maternal interleukin 6 level for determination of histologic chorioamnionitis in preterm delivery",
            "volume": "43"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Rafli",
                    "initial": "R.",
                    "last": "van de Laar"
                },
                {
                    "first": "David P.",
                    "initial": "D.P.",
                    "last": "van der Ham"
                },
                {
                    "first": "S. Guid",
                    "initial": "S.G.",
                    "last": "Oei"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Willekes"
                },
                {
                    "first": "Carl P.",
                    "initial": "C.P.",
                    "last": "Weiner"
                },
                {
                    "first": "Ben W.J.",
                    "initial": "B.W.J.",
                    "last": "Mol"
                }
            ],
            "doi": "10.1016/j.ejogrb.2009.09.017",
            "firstpage": "124",
            "issn": "03012115",
            "lastpage": "129",
            "pmid": "19819609",
            "pub_year": 2009,
            "title": "Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: A systematic review",
            "volume": "147"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Ctirad",
                    "initial": "C.",
                    "last": "Andrys"
                },
                {
                    "first": "Marcela",
                    "initial": "M.",
                    "last": "Drahosova"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "Hornychova"
                },
                {
                    "first": "Vojtech",
                    "initial": "V.",
                    "last": "Tambor"
                },
                {
                    "first": "Ivana",
                    "initial": "I.",
                    "last": "Musilova"
                },
                {
                    "first": "Jindrich",
                    "initial": "J.",
                    "last": "Tosner"
                },
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Flidrova"
                },
                {
                    "first": "Marian",
                    "initial": "M.",
                    "last": "Kacerovsky"
                }
            ],
            "firstpage": "857",
            "issn": "0172780X",
            "lastpage": "863",
            "pmid": "21196908",
            "pub_year": 2010,
            "title": "Umbilical cord blood concentrations of IL-6, IL-8, and MMP-8 in pregnancy complicated by preterm premature rupture of the membranes and histological chorioamnionitis",
            "volume": "31"
        },
        "b0250": {
            "authors": [
                {
                    "first": "Christian M.",
                    "initial": "C.M.",
                    "last": "Pettker"
                },
                {
                    "first": "Irina A.",
                    "initial": "I.A.",
                    "last": "Buhimschi"
                },
                {
                    "first": "Lissa K.",
                    "initial": "L.K.",
                    "last": "Magloire"
                },
                {
                    "first": "Anna K.",
                    "initial": "A.K.",
                    "last": "Sfakianaki"
                },
                {
                    "first": "Benjamin D.",
                    "initial": "B.D.",
                    "last": "Hamar"
                },
                {
                    "first": "Catalin S.",
                    "initial": "C.S.",
                    "last": "Buhimschi"
                }
            ],
            "doi": "10.1097/01.AOG.0000255663.47512.23",
            "firstpage": "739",
            "issn": "00297844",
            "lastpage": "749",
            "pmid": "17329528",
            "pub_year": 2007,
            "title": "Value of placental microbial evaluation in diagnosing intra-amniotic infection",
            "volume": "109"
        },
        "b0255": {
            "authors": [
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Holzman"
                },
                {
                    "first": "Ximin",
                    "initial": "X.",
                    "last": "Lin"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Senagore"
                },
                {
                    "first": "Hwan",
                    "initial": "H.",
                    "last": "Chung"
                }
            ],
            "doi": "10.1093/aje/kwm168",
            "firstpage": "786",
            "issn": "00029262",
            "lastpage": "794",
            "pmid": "17625222",
            "pub_year": 2007,
            "title": "Histologic chorioamnionitis and preterm delivery",
            "volume": "166"
        },
        "b0260": {
            "authors": [
                {
                    "first": "Raymond W.",
                    "initial": "R.W.",
                    "last": "Redline"
                },
                {
                    "first": "Ona",
                    "initial": "O.",
                    "last": "Faye-Petersen"
                },
                {
                    "first": "Debra",
                    "initial": "D.",
                    "last": "Heller"
                },
                {
                    "first": "Faisal",
                    "initial": "F.",
                    "last": "Qureshi"
                },
                {
                    "first": "Van",
                    "initial": "V.",
                    "last": "Savell"
                },
                {
                    "first": "Carole",
                    "initial": "C.",
                    "last": "Vogler"
                }
            ],
            "doi": "10.1007/s10024-003-7070-y",
            "firstpage": "435",
            "issn": "10935266",
            "lastpage": "448",
            "pmid": "14708737",
            "pub_year": 2003,
            "title": "Amniotic Infection Syndrome: Nosology and Reproducibility of Placental Reaction Patterns",
            "volume": "6"
        },
        "b0265": {
            "authors": [
                {
                    "first": "W. A.",
                    "initial": "W.A.",
                    "last": "Blanc"
                }
            ],
            "firstpage": "67",
            "issn": "00770922",
            "lastpage": "132",
            "pmid": "7024790",
            "pub_year": 1981,
            "title": "Pathology of the placenta, membranes, and umbilical cord in bacterial, fungal, and viral infections in man."
        },
        "b0270": {
            "authors": [
                {
                    "first": "Catalin S.",
                    "initial": "C.S.",
                    "last": "Buhimschi"
                },
                {
                    "first": "Vineet",
                    "initial": "V.",
                    "last": "Bhandari"
                },
                {
                    "first": "Benjamin D.",
                    "initial": "B.D.",
                    "last": "Hamar"
                },
                {
                    "first": "Mert Ozan",
                    "initial": "M.O.",
                    "last": "Bahtiyar"
                },
                {
                    "first": "Guomao",
                    "initial": "G.",
                    "last": "Zhao"
                },
                {
                    "first": "Anna K.",
                    "initial": "A.K.",
                    "last": "Sfakianaki"
                },
                {
                    "first": "Christian M.",
                    "initial": "C.M.",
                    "last": "Pettker"
                },
                {
                    "first": "Lissa",
                    "initial": "L.",
                    "last": "Magloire"
                },
                {
                    "first": "Edmund",
                    "initial": "E.",
                    "last": "Funai"
                },
                {
                    "first": "Errol R.",
                    "initial": "E.R.",
                    "last": "Norwitz"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Paidas"
                },
                {
                    "first": "Joshua A.",
                    "initial": "J.A.",
                    "last": "Copel"
                },
                {
                    "first": "Carl P.",
                    "initial": "C.P.",
                    "last": "Weiner"
                },
                {
                    "first": "Charles J.",
                    "initial": "C.J.",
                    "last": "Lockwood"
                },
                {
                    "first": "Irina A.",
                    "initial": "I.A.",
                    "last": "Buhimschi"
                }
            ],
            "doi": "10.1371/journal.pmed.0040018",
            "firstpage": "0084",
            "issn": "15491277",
            "lastpage": "0094",
            "pmid": "17227133",
            "pub_year": 2007,
            "title": "Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis",
            "volume": "4"
        },
        "b0275": {
            "authors": [
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Hitti"
                },
                {
                    "first": "Donald E.",
                    "initial": "D.E.",
                    "last": "Riley"
                },
                {
                    "first": "Marijane A.",
                    "initial": "M.A.",
                    "last": "Krohn"
                },
                {
                    "first": "Sharon L.",
                    "initial": "S.L.",
                    "last": "Hillier"
                },
                {
                    "first": "Kathy J.",
                    "initial": "K.J.",
                    "last": "Agnew"
                },
                {
                    "first": "John N.",
                    "initial": "J.N.",
                    "last": "Krieger"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Eschenbach"
                }
            ],
            "doi": "10.1086/513669",
            "firstpage": "1228",
            "issn": "10584838",
            "lastpage": "1232",
            "pmid": "9195088",
            "pub_year": 1997,
            "title": "Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor",
            "volume": "24"
        },
        "b0280": {
            "authors": [
                {
                    "first": "Caroline E.",
                    "initial": "C.E.",
                    "last": "Rouse"
                },
                {
                    "first": "Linda O.",
                    "initial": "L.O.",
                    "last": "Eckert"
                },
                {
                    "first": "Isaac",
                    "initial": "I.",
                    "last": "Babarinsa"
                },
                {
                    "first": "Emily",
                    "initial": "E.",
                    "last": "Fay"
                },
                {
                    "first": "Manish",
                    "initial": "M.",
                    "last": "Gupta"
                },
                {
                    "first": "Margo S.",
                    "initial": "M.S.",
                    "last": "Harrison"
                },
                {
                    "first": "Alison Tse",
                    "initial": "A.T.",
                    "last": "Kawai"
                },
                {
                    "first": "Elyse O.",
                    "initial": "E.O.",
                    "last": "Kharbanda"
                },
                {
                    "first": "Merita",
                    "initial": "M.",
                    "last": "Kucuku"
                },
                {
                    "first": "Lee",
                    "initial": "L.",
                    "last": "Meller"
                },
                {
                    "first": "Tamala",
                    "initial": "T.",
                    "last": "Mallett Moore"
                },
                {
                    "first": "Maja",
                    "initial": "M.",
                    "last": "Subelj"
                },
                {
                    "first": "Sonali",
                    "initial": "S.",
                    "last": "Kochhar"
                },
                {
                    "first": "Fernanda",
                    "initial": "F.",
                    "last": "Tavares-Da-Silva"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2017.01.047",
            "firstpage": "6563",
            "issn": "0264410X",
            "lastpage": "6574",
            "pmid": "29150062",
            "pub_year": 2017,
            "title": "Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data",
            "volume": "35"
        },
        "b0285": {
            "authors": [
                {
                    "first": "Julie Anne",
                    "initial": "J.A.",
                    "last": "Quinn"
                },
                {
                    "first": "Flor M.",
                    "initial": "F.M.",
                    "last": "Munoz"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Gonik"
                },
                {
                    "first": "Lourdes",
                    "initial": "L.",
                    "last": "Frau"
                },
                {
                    "first": "Clare",
                    "initial": "C.",
                    "last": "Cutland"
                },
                {
                    "first": "Tamala",
                    "initial": "T.",
                    "last": "Mallett-Moore"
                },
                {
                    "first": "Aimee",
                    "initial": "A.",
                    "last": "Kissou"
                },
                {
                    "first": "Frederick",
                    "initial": "F.",
                    "last": "Wittke"
                },
                {
                    "first": "Manoj",
                    "initial": "M.",
                    "last": "Das"
                },
                {
                    "first": "Tony",
                    "initial": "T.",
                    "last": "Nunes"
                },
                {
                    "first": "Savia",
                    "initial": "S.",
                    "last": "Pye"
                },
                {
                    "first": "Wendy",
                    "initial": "W.",
                    "last": "Watson"
                },
                {
                    "first": "Ana Maria Alguacil",
                    "initial": "A.M.A.",
                    "last": "Ramos"
                },
                {
                    "first": "Jose F.",
                    "initial": "J.F.",
                    "last": "Cordero"
                },
                {
                    "first": "Wan Ting",
                    "initial": "W.T.",
                    "last": "Huang"
                },
                {
                    "first": "Sonali",
                    "initial": "S.",
                    "last": "Kochhar"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Buttery"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2016.03.045",
            "firstpage": "6047",
            "issn": "0264410X",
            "lastpage": "6056",
            "pmid": "27743648",
            "pub_year": 2016,
            "title": "Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data",
            "volume": "34"
        },
        "b0290": {
            "authors": [
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Bonhoeffer"
                },
                {
                    "first": "Katrin",
                    "initial": "K.",
                    "last": "Kohl"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Chen"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Duclos"
                },
                {
                    "first": "Harald",
                    "initial": "H.",
                    "last": "Heijbel"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Heininger"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Jefferson"
                },
                {
                    "first": "Elisabeth",
                    "initial": "E.",
                    "last": "Loupi"
                }
            ],
            "doi": "10.1016/S0264-410X(02)00449-8",
            "firstpage": "298",
            "issn": "0264410X",
            "lastpage": "302",
            "pmid": "12450705",
            "pub_year": 2002,
            "title": "The Brighton Collaboration: Addressing the need for standardized case definitions of adverse events following immunization (AEFI)",
            "volume": "21"
        },
        "b0295": null,
        "b0300": null,
        "b0305": {
            "authors": [
                {
                    "first": "Gabriela",
                    "initial": "G.",
                    "last": "Vazquez-Benitez"
                },
                {
                    "first": "Elyse O.",
                    "initial": "E.O.",
                    "last": "Kharbanda"
                },
                {
                    "first": "Allison L.",
                    "initial": "A.L.",
                    "last": "Naleway"
                },
                {
                    "first": "Heather",
                    "initial": "H.",
                    "last": "Lipkind"
                },
                {
                    "first": "Lakshmi",
                    "initial": "L.",
                    "last": "Sukumaran"
                },
                {
                    "first": "Natalie L.",
                    "initial": "N.L.",
                    "last": "McCarthy"
                },
                {
                    "first": "Saad B.",
                    "initial": "S.B.",
                    "last": "Omer"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Qian"
                },
                {
                    "first": "Stanley",
                    "initial": "S.",
                    "last": "Xu"
                },
                {
                    "first": "Michael L.",
                    "initial": "M.L.",
                    "last": "Jackson"
                },
                {
                    "first": "Vinutha",
                    "initial": "V.",
                    "last": "Vijayadev"
                },
                {
                    "first": "Nicola P.",
                    "initial": "N.P.",
                    "last": "Klein"
                },
                {
                    "first": "James D.",
                    "initial": "J.D.",
                    "last": "Nordin"
                }
            ],
            "doi": "10.1093/aje/kww043",
            "firstpage": "176",
            "issn": "00029262",
            "lastpage": "186",
            "pmid": "27449414",
            "pub_year": 2016,
            "title": "Risk of Preterm or Small-for-Gestational-Age Birth after Influenza Vaccination during Pregnancy: Caveats When Conducting Retrospective Observational Studies",
            "volume": "184"
        },
        "b0310": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Moher"
                },
                {
                    "first": "Kenneth F.",
                    "initial": "K.F.",
                    "last": "Schulz"
                },
                {
                    "first": "Douglas",
                    "initial": "D.",
                    "last": "Altman"
                }
            ],
            "doi": "10.1001/jama.285.15.1987",
            "firstpage": "1987",
            "issn": "00987484",
            "lastpage": "1991",
            "pmid": "11308435",
            "pub_year": 2001,
            "title": "The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials",
            "volume": "285"
        },
        "b0315": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Moher"
                },
                {
                    "first": "Deborah J.",
                    "initial": "D.J.",
                    "last": "Cook"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Eastwood"
                },
                {
                    "first": "Ingram",
                    "initial": "I.",
                    "last": "Olkin"
                },
                {
                    "first": "Drummond",
                    "initial": "D.",
                    "last": "Rennie"
                },
                {
                    "first": "Donna F.",
                    "initial": "D.F.",
                    "last": "Stroup"
                }
            ],
            "doi": "10.1016/S0140-6736(99)04149-5",
            "firstpage": "1896",
            "issn": "01406736",
            "lastpage": "1900",
            "pmid": "10584742",
            "pub_year": 1999,
            "title": "Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement",
            "volume": "354"
        },
        "b0320": {
            "authors": [
                {
                    "first": "Donna F.",
                    "initial": "D.F.",
                    "last": "Stroup"
                },
                {
                    "first": "Jesse A.",
                    "initial": "J.A.",
                    "last": "Berlin"
                },
                {
                    "first": "Sally C.",
                    "initial": "S.C.",
                    "last": "Morton"
                },
                {
                    "first": "Ingram",
                    "initial": "I.",
                    "last": "Olkin"
                },
                {
                    "first": "G. David",
                    "initial": "G.D.",
                    "last": "Williamson"
                },
                {
                    "first": "Drummond",
                    "initial": "D.",
                    "last": "Rennie"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Moher"
                },
                {
                    "first": "Betsy J.",
                    "initial": "B.J.",
                    "last": "Becker"
                },
                {
                    "first": "Theresa Ann",
                    "initial": "T.A.",
                    "last": "Sipe"
                },
                {
                    "first": "Stephen B.",
                    "initial": "S.B.",
                    "last": "Thacker"
                }
            ],
            "doi": "10.1001/jama.283.15.2008",
            "firstpage": "2008",
            "issn": "00987484",
            "lastpage": "2012",
            "pmid": "10789670",
            "pub_year": 2000,
            "title": "Meta-analysis of observational studies in epidemiology: A proposal for reporting",
            "volume": "283"
        },
        "b0325": {
            "authors": [
                {
                    "first": "Robert L.",
                    "initial": "R.L.",
                    "last": "Goldenberg"
                },
                {
                    "first": "John C.",
                    "initial": "J.C.",
                    "last": "Hauth"
                },
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Andrews"
                }
            ],
            "doi": "10.1056/NEJM200005183422007",
            "firstpage": "1500",
            "issn": "00284793",
            "lastpage": "1507",
            "pmid": "10816189",
            "pub_year": 2000,
            "title": "Intrauterine infection and preterm delivery",
            "volume": "342"
        }
    },
    "body_text": [
        {
            "endOffset": 41248,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Subsequent studies have, for the most part, used variations of these clinical criteria.",
            "startOffset": 41161,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 40610,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Uterine tenderness is assessed via physical examination and may be confounded by contraction pain or masked by epidural anesthesia.",
            "startOffset": 40479,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 51376,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Instead, wherever feasible, details of this interval should be assessed and reported as described in the data collection guidelines.",
            "startOffset": 51244,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 45509,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Influence of treatment on fulfilment of case definition",
            "startOffset": 45454,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 62827,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Values and units of routinely measured parameters (e.g. temperature, blood pressure) \u2013 in particular those indicating the severity of the event;",
            "startOffset": 62683,
            "title": "The adverse event"
        },
        {
            "endOffset": 70246,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Increments specified above should be used.",
            "startOffset": 70204,
            "title": "Data analysis"
        },
        {
            "endOffset": 73444,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "The instrument of data collection (e.g. standardized questionnaire, diary card, report form);",
            "startOffset": 73351,
            "title": "Data presentation"
        },
        {
            "endOffset": 73350,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Comparison group(s), if used for analysis;",
            "startOffset": 73308,
            "title": "Data presentation"
        },
        {
            "endOffset": 30914,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The searches in MEDLINE, Embase, and Web of Science yielded a total of 9710 citations.",
            "startOffset": 30828,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 62614,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Date/time of onset14, first observation15 and diagnosis16, end of episode17 (i.e. time of delivery or termination of pregnancy) and final outcome18 (i.e. development of postpartum endometritis or sepsis, need for further procedures such as hysterectomy, or neonatal outcomes).",
            "startOffset": 61355,
            "title": "The adverse event"
        },
        {
            "endOffset": 39575,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0230": {
                    "endOffset": 39574,
                    "startOffset": 39570
                }
            },
            "secId": "s0040",
            "sentence": "For the purposes of this case definition, we will use the case definition for fever that was previously developed by the Brighton Collaboration which defines fever as temperature \u226538 degrees Celsius on one occasion [46].",
            "startOffset": 39355,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 28848,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Furthermore, based on these studies it is clear that heterogeneity of diagnostic criteria for chorioamnionitis makes it difficult to draw conclusions about whether associations between maternal immunization with Tdap vaccine or any other recommended vaccines during pregnancy and an increased risk of chorioamnionitis actually exist.",
            "startOffset": 28515,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 33509,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "Pathologic placental findings consistent with chorioamnionitis are usually referred to as \u201chistologic chorioamnionitis.\u201d",
            "startOffset": 33389,
            "title": "The term chorioamnionitis"
        },
        {
            "endOffset": 50034,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0280": {
                    "endOffset": 50033,
                    "startOffset": 50029
                }
            },
            "secId": "s0050",
            "sentence": "The Brighton Collaboration definition for abortion is loss of pregnancy at less than or equal to 21-6/7 weeks gestational age [56].",
            "startOffset": 49903,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 19252,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Distinction of inflammatory versus infectious etiology within the spectrum of chorioamnionitis is therefore important, given the profound differences on subsequent maternal and neonatal morbidity.",
            "startOffset": 19056,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 38856,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Clinical findings described in published literature that are important for the diagnosis of clinical chorioamnionitis include maternal fever, uterine tenderness, maternal tachycardia, fetal tachycardia, and purulent fluid coming from the cervical os.",
            "startOffset": 38606,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 40906,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Diagnosis of clinical chorioamnionitis is largely based on two different algorithms.",
            "startOffset": 40822,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 51607,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "In some settings it may be impossible to obtain a clear timeline of the event, particularly in less developed or rural settings.",
            "startOffset": 51479,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 35274,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Fetal inflammatory response syndrome (FIRS)",
            "startOffset": 35231,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 50162,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Diagnostic criteria of chorioamnionitis should therefore include a gestational age greater than or equal to 22 completed weeks.",
            "startOffset": 50035,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 53433,
            "parents": [],
            "secId": "s0065",
            "sentence": "Level 1 of diagnostic certainty",
            "startOffset": 53402,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 60950,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "Needle length and gauge.",
            "startOffset": 60926,
            "title": "Details of the maternal immunization"
        },
        {
            "endOffset": 70047,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Analysis may also include other characteristics like qualitative patterns of criteria defining the event.",
            "startOffset": 69942,
            "title": "Data analysis"
        },
        {
            "endOffset": 56745,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0075",
            "sentence": "The guidelines are not intended to guide the primary reporting of chorioamnionitis to a surveillance system or study monitor.",
            "startOffset": 56620,
            "title": "Data collection"
        },
        {
            "endOffset": 20683,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Maternal and neonatal outcomes",
            "startOffset": 20653,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 22906,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "These challenges require that we develop a case definition for chorioamnionitis with levels of certainty that are appropriately sensitive and specific for any clinical setting.",
            "startOffset": 22730,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 55298,
            "parents": [],
            "secId": "s0065",
            "sentence": "Clinical chorioamnionitis (definition B \u2013 See Section 1.3.5) without fever (documented or reported)",
            "startOffset": 55199,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 27438,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Another retrospective cohort study of 1759 women was published by Berensen et al in 2016.",
            "startOffset": 27349,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 32064,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Of the search for chorioamnionitis related to vaccinations, 23 were selected after review.",
            "startOffset": 31974,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 54807,
            "parents": [],
            "secId": "s0065",
            "sentence": "Clinical chorioamnionitis (definition A or B \u2013 See Section 1.3.5) with at least one measurement of maternal temperature \u2265 38 degrees Celsius.",
            "startOffset": 54666,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 35390,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Describes a systemic inflammatory response within the fetus stemming from microbial invasion of the fetus in utero.",
            "startOffset": 35275,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 37873,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The number of signs and/or symptoms that will be documented for each case may vary considerably.",
            "startOffset": 37777,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 39015,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Persistent maternal temperature \u226538 degrees Celsius or 100.4 degrees Fahrenheit is considered an abnormal finding during the antepartum and intrapartum period.",
            "startOffset": 38856,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 51478,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Further, chorioamnionitis often occurs outside the controlled setting of a clinical trial or hospital.",
            "startOffset": 51376,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 30246,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0210": {
                    "endOffset": 29960,
                    "startOffset": 29956
                }
            },
            "secId": "s0015",
            "sentence": "Due to the lack of a clear definition for chorioamnionitis to facilitate data comparability across trials and surveillance systems, and following the process described in the GAIA overview paper [42] as well as on the Brighton Collaboration Website, https://www.brightoncollaboration.org/about-us/vision-and-mission.html, the Brighton Collaboration Chorioamnionitis Working Group was formed in 2018 and included members from clinical, academic, public health, and industry backgrounds.",
            "startOffset": 29761,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 35450,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 35449,
                    "startOffset": 35445
                }
            },
            "secId": "s0030",
            "sentence": "FIRS correlates with histologic findings of funisitis [27].",
            "startOffset": 35391,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 45667,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "The Working Group decided against using \u201cantibiotic treatment\u201d or \u201cantibiotic treatment response\u201d towards fulfillment of the chorioamnionitis case definition.",
            "startOffset": 45509,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 58361,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 58269,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 66135,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 65993,
            "title": "Data analysis"
        },
        {
            "endOffset": 67724,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Reported chorioamnionitis with insufficient evidence to meet the case definition21",
            "startOffset": 67431,
            "title": "Data analysis"
        },
        {
            "endOffset": 26171,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 26170,
                    "startOffset": 26166
                }
            },
            "secId": "s0010",
            "sentence": "Chorioamnionitis was diagnosed in 6.1% and 5.5% of women who did and did not receive the tetanus toxoid, diptheria and acellular pertussis (Tdap) vaccine during pregnancy, respectively, demonstrating a small, but significant difference in chorioamnionitis rates (risk ratio [RR] 1.19; 95% confidence interval [CI] 1.13\u20131.26) [34].",
            "startOffset": 25841,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 26258,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In this study, chorioamnionitis cases were identified retrospectively via ICD-9 codes.",
            "startOffset": 26172,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 32418,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "A manual search of references was conducted for relevant and landmark papers of which 12 studies were selected.",
            "startOffset": 32307,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 30692,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Due to the extensive and diverse topic of chorioamnionitis, the search was limited from 1995 to the date that the search was conducted in February 2018.",
            "startOffset": 30540,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 18536,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0010": {
                    "endOffset": 18535,
                    "startOffset": 18530
                },
                "b0015": {
                    "endOffset": 18535,
                    "startOffset": 18530
                }
            },
            "secId": "s0010",
            "sentence": "The clinical presentation of chorioamnionitis can vary based on clinical, microbiologic, and histologic factors which interact and overlap to varying degrees [2,3].",
            "startOffset": 18372,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 21850,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The diagnosis of chorioamnionitis has been made in previous studies by varying clinical criteria, laboratory, and histologic findings.",
            "startOffset": 21716,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 58861,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0090",
            "sentence": "For infants: Gestational age and birth weight.",
            "startOffset": 58815,
            "title": "Demographics"
        },
        {
            "endOffset": 19470,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "For the purposes of this case definition we will focus on the infectious manifestation of chorioamnionitis, intra-amniotic infection, and will use these terms interchangeably throughout the remainder of this document.",
            "startOffset": 19253,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 65860,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on chorioamnionitis to allow for comparability of data and are recommended as an addition to data analyzed for the specific study question and setting.",
            "startOffset": 65632,
            "title": "Data analysis"
        },
        {
            "endOffset": 68567,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "If few cases are reported, the concrete time course could be analyzed for each.",
            "startOffset": 68488,
            "title": "Data analysis"
        },
        {
            "endOffset": 23640,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0010": {
                    "endOffset": 23639,
                    "startOffset": 23630
                },
                "b0115": {
                    "endOffset": 23639,
                    "startOffset": 23630
                },
                "b0130": {
                    "endOffset": 23639,
                    "startOffset": 23630
                }
            },
            "secId": "s0010",
            "sentence": "The presence of multiple criteria for clinical chorioamnionitis as well as risk factors has a higher correlation with histologic chorioamnionitis, while individual clinical chorioamnionitis criteria on their own have variable sensitivity and low specificity [2,23,26].",
            "startOffset": 23372,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 59916,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0095",
            "sentence": "Immunization history (i.e. previous immunizations and any adverse event following immunization (AEFI)), in particular occurrence of chorioamnionitis after a previous immunization in pregnancy.",
            "startOffset": 59724,
            "title": "Clinical and maternal immunization history"
        },
        {
            "endOffset": 29581,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0190": {
                    "endOffset": 29580,
                    "startOffset": 29573
                },
                "b0195": {
                    "endOffset": 29580,
                    "startOffset": 29573
                },
                "b0200": {
                    "endOffset": 29580,
                    "startOffset": 29573
                },
                "b0205": {
                    "endOffset": 29580,
                    "startOffset": 29573
                }
            },
            "secId": "s0010",
            "sentence": "Most countries recommend acellular pertussis routinely during pregnancy, while WHO recommends the acellular pertussis vaccine specifically in areas of high disease burden [38\u201341].",
            "startOffset": 29402,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 63221,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Outcome (see Footnote 17) at last observation.",
            "startOffset": 63175,
            "title": "The adverse event"
        },
        {
            "endOffset": 44366,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 44365,
                    "startOffset": 44361
                }
            },
            "secId": "s0040",
            "sentence": "Similarly, positive culture results for pathogenic bacteria from swabs between the layers of the placental membrane, the chorion and amnion, correlate with intraamniotic infection [22].",
            "startOffset": 44181,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 20653,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 20652,
                    "startOffset": 20644
                },
                "b0040": {
                    "endOffset": 20652,
                    "startOffset": 20644
                },
                "b0045": {
                    "endOffset": 20652,
                    "startOffset": 20644
                },
                "b0050": {
                    "endOffset": 20652,
                    "startOffset": 20644
                },
                "b0055": {
                    "endOffset": 20652,
                    "startOffset": 20644
                },
                "b0060": {
                    "endOffset": 20652,
                    "startOffset": 20644
                }
            },
            "secId": "s0010",
            "sentence": "There are multiple studies reporting risk factors for chorioamnionitis, which include prelabor rupture of membranes, prolonged labor, nulliparity, internal intrapartum fetal monitoring, multiple vaginal exams, alcohol and tobacco use, bacterial vaginosis, colonization with group B streptococcus, and colonization with Ureaplasma urealyticum (genital mycoplasmas) and other pathogens [5,8\u201312].",
            "startOffset": 20260,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 42985,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "The association between histologic findings of chorioamnionitis in the placenta and infection is well established.",
            "startOffset": 42871,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 72584,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 72459,
            "title": "Data presentation"
        },
        {
            "endOffset": 52390,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0060",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e. every three to five years) or more often if needed.",
            "startOffset": 52187,
            "title": "Periodic review"
        },
        {
            "endOffset": 62929,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Method of measurement (e.g. type of thermometer, oral or other route, duration of measurement, etc.);",
            "startOffset": 62828,
            "title": "The adverse event"
        },
        {
            "endOffset": 27642,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "They did not find statistically significant differences in chorioamnionitis rates between those who were and those who were not vaccinated with Tdap during pregnancy (adjusted OR 1.53, 95% CI 0.80\u20132.90).",
            "startOffset": 27439,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 53072,
            "parents": [],
            "secId": "s0065",
            "sentence": "It is important to rule out other obvious sources of acute systemic infection (i.e. pyelonephritis) prior to chorioamnionitis diagnosis.",
            "startOffset": 52936,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 54112,
            "parents": [],
            "secId": "s0065",
            "sentence": "Gestational age \u2265 22\u20130/7 weeks by any GAIA gestational age criteria (Annex 1)",
            "startOffset": 54035,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 67213,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Level 1: Criteria as specified in the chorioamnionitis case definition",
            "startOffset": 67143,
            "title": "Data analysis"
        },
        {
            "endOffset": 36828,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The focus of this Brighton Collaboration case definition is on chorioamnionitis with three levels of diagnostic certainty.",
            "startOffset": 36706,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 47896,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Baseline fetal tachycardia (FHR > 160 bpm for 10 min or longer, excluding accelerations, decelerations and periods of marked variability5 or, where continuous monitoring is not available, an FHR exceeding 160 bpm during and after at least three consecutive contractions6)",
            "startOffset": 47244,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 31019,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "These were exported to Endnote and 2755 duplicates were removed using the Endnote deduplication feature.",
            "startOffset": 30915,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 55845,
            "parents": [],
            "secId": "s0070",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 55765,
            "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
        },
        {
            "endOffset": 40350,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "There are several non-infectious causes for maternal tachycardia such as medication side effects, hemodynamic changes, and pain; while non-infectious causes for sustained fetal tachycardia are less common, but can include maternal illness, hypoexemia, tachyarrhythmia or prematurity.",
            "startOffset": 40067,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 41378,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "A second algorithm for clinical chorioamnionitis was developed during an expert panel workshop at the NICHD in the United States.",
            "startOffset": 41249,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 63171,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Treatment given for chorioamnionitis, especially specify what antibiotics and additional medications were administered and at what dosing.",
            "startOffset": 63033,
            "title": "The adverse event"
        },
        {
            "endOffset": 28515,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There is also a possibility that these studies were underpowered which decreases the likelihood of finding differences in chorioamnionitis outcomes between women who were vaccinated in pregnancy and women who were not.",
            "startOffset": 28297,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 70362,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "When only a small number of cases is presented, the respective values or time course can be presented individually.",
            "startOffset": 70247,
            "title": "Data analysis"
        },
        {
            "endOffset": 70877,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on chorioamnionitis following immunization to allow for comparability of data and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 70609,
            "title": "Data presentation"
        },
        {
            "endOffset": 52923,
            "parents": [],
            "secId": "s0065",
            "sentence": "Levels of diagnostic certainty for chorioamnionitis in Part 2 should always be interpreted conjointly with the discussion in Section 1.3.5.",
            "startOffset": 52784,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 73978,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Use of this case definition for chorioamnionitis, in the abstract or methods section of a publication23.",
            "startOffset": 73706,
            "title": "Data presentation"
        },
        {
            "endOffset": 25279,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "While these definitions describe chorioamnionitis, they provide limited guidance regarding diagnostic criteria.",
            "startOffset": 25168,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 46104,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "This is especially pertinent in chorioamnionitis cases since while antibiotics are typically administered to treat clinical signs and symptoms, the ultimate treatment is evacuation of the uterus via childbirth or termination of pregnancy.",
            "startOffset": 45866,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 55451,
            "parents": [],
            "secId": "s0065",
            "sentence": "Major and Minor Criteria used in the Case Definition of Chorioamnionitis",
            "startOffset": 55379,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 19597,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Although chorioamnionitis may affect neonatal morbidity, we will focus on manifestations and pathology found during pregnancy.",
            "startOffset": 19471,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 58617,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0090",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 58511,
            "title": "Demographics"
        },
        {
            "endOffset": 68701,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Subjects with Chorioamnionitis by Interval to Presentation",
            "startOffset": 68643,
            "title": "Data analysis"
        },
        {
            "endOffset": 24706,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 24705,
                    "startOffset": 24698
                },
                "b0150": {
                    "endOffset": 24705,
                    "startOffset": 24698
                }
            },
            "secId": "s0010",
            "sentence": "The WHO\u2019s International Classification of Diseases ICD-10 and ICD-11 define chorioamnionitis as O41.12X \u201cChorioamnionitis\u201d and as JA88.1 \u201cInfection of the amniotic sac and membranes,\u201d respectively [29,30].",
            "startOffset": 24501,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 46592,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "It is important to note that Clinical Definition A and Clinical definition B were included as separate entities given their widespread use and historic significance.",
            "startOffset": 46427,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 67113,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Event classification in 5 categories20",
            "startOffset": 66243,
            "title": "Data analysis"
        },
        {
            "endOffset": 69373,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Whatever start and ending are used, they should be used consistently within and across study groups.",
            "startOffset": 69273,
            "title": "Data analysis"
        },
        {
            "endOffset": 48443,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Maternal fever \u2265 38 degrees Celsius on one occasion.8",
            "startOffset": 48247,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 49143,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Baseline fetal tachycardia (FHR > 160 bpm for 10 min or longer, excluding accelerations, decelerations and periods of marked variability9 or, where continuous monitoring is not available, an FHR exceeding 160 bpm during and after at least three consecutive contractions10)",
            "startOffset": 48489,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 34998,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "This term is not used within this case definition as it can cause confusion, especially outside of the United States, and because the goal of this case definition is to focus on chorioamnionitis as an intra-amnionitic infection.",
            "startOffset": 34770,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 56105,
            "parents": [],
            "secId": "s0070",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, a post-marketing surveillance or epidemiological study, or an individual report of chorioamnionitis.",
            "startOffset": 55846,
            "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
        },
        {
            "endOffset": 70589,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Data on chorioamnionitis obtained from subjects receiving a vaccine should be compared with those obtained from an appropriately selected and documented control group(s) to assess background rates in non-exposed populations",
            "startOffset": 70366,
            "title": "Data analysis"
        },
        {
            "endOffset": 59359,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0095",
            "sentence": "Past medical and obstetric history, including hospitalizations, underlying diseases/disorders, infections during pregnancy, pre-immunization signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications; food allergy; allergic rhinitis; eczema; asthma.",
            "startOffset": 59019,
            "title": "Clinical and maternal immunization history"
        },
        {
            "endOffset": 52783,
            "parents": [],
            "secId": "s0065",
            "sentence": "Criteria refer to the factors described in Section 1.3 above.",
            "startOffset": 52722,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 41160,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 41159,
                    "startOffset": 41155
                }
            },
            "secId": "s0040",
            "sentence": "The Gibbs criteria for clinical chorioamnionitis or intraamniotic infection includes maternal fever plus two or more findings of maternal tachycardia, fetal tachycardia, uterine tenderness, foul odor of the amniotic fluid, or maternal leukocytosis [25].",
            "startOffset": 40907,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 51736,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "In order to avoid selecting against such cases, the Brighton Collaboration case definition avoids setting arbitrary time frames.",
            "startOffset": 51608,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 45101,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 45100,
                    "startOffset": 45097
                }
            },
            "secId": "s0040",
            "sentence": "The risk of iatrogenic intra-amniotic infection from invasive fetal therapy or prenatal diagnostic procedures is low if appropriate precautions are taken [4].",
            "startOffset": 44943,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 49902,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Chorioamnionitis is largely distinguished from septic abortion based on gestational age of the pregnancy.",
            "startOffset": 49797,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 44180,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 44179,
                    "startOffset": 44175
                }
            },
            "secId": "s0040",
            "sentence": "While numerous studies have shown correlation between positive amniotic fluid culture and chorioamnionitis, positive fluid cultures can also be found in subclinical infections [21].",
            "startOffset": 43999,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 49265,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Maternal WBC \u2265 15,000 per mm3 in the absence of corticosteroids.",
            "startOffset": 49201,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 71950,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 71844,
            "title": "Data presentation"
        },
        {
            "endOffset": 34179,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "For the purposes of developing this case definition, the focus is on the intraamniotic infectious manifestation of chorioamnionitis that occurs during pregnancy.",
            "startOffset": 34018,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 42848,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0235": {
                    "endOffset": 42847,
                    "startOffset": 42840
                },
                "b0240": {
                    "endOffset": 42847,
                    "startOffset": 42840
                },
                "b0245": {
                    "endOffset": 42847,
                    "startOffset": 42840
                }
            },
            "secId": "s0040",
            "sentence": "Other laboratory tests such as C-reactive protein, interleukin-6, soluble intracellular adhesion molecule (sICAM), procalcitonin, lipopolysaccharide binding protein (LBP) and metalloproteinase-8 exist, however, they are of limited value clinically and often used only in research settings [47\u201349].",
            "startOffset": 42551,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 30353,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the working and reference group can be viewed at: http://www.brightoncollaboration.org.",
            "startOffset": 30247,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 63029,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Results of laboratory examinations, surgical and/or pathological findings and diagnoses if present.",
            "startOffset": 62930,
            "title": "The adverse event"
        },
        {
            "endOffset": 29401,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Vaccines currently routinely recommended in pregnancy by WHO and national health authorities in the United Kingdom, the United States, Australia, and an increasing number of countries include tetanus toxoid and inactivated influenza vaccines.",
            "startOffset": 29159,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 42550,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Antenatal corticosteroids are especially pertinent since they are often given to patients who are also at high risk for developing chorioamnionitis, such as those with preterm labor and preterm premature rupture of membranes.",
            "startOffset": 42325,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 54956,
            "parents": [],
            "secId": "s0065",
            "sentence": "Gestational age \u2265 22\u20130/7 weeks by any GAIA gestational age criteria (Annex 1)",
            "startOffset": 54879,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 74284,
            "parents": [],
            "secId": "s0125",
            "sentence": "They do not necessarily represent the official positions of each participant\u2019s organization (e.g., government, university, or corporation).",
            "startOffset": 74145,
            "title": "Disclaimer"
        },
        {
            "endOffset": 49180,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Purulent fluid from the cervical os.",
            "startOffset": 49144,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 58471,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Relation to the patient (e.g., immunizer [clinician, nurse], family member [indicate relationship], other).",
            "startOffset": 58364,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 19640,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Epidemiology, pathogenesis and risk factors",
            "startOffset": 19597,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 19921,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0030": {
                    "endOffset": 19920,
                    "startOffset": 19917
                }
            },
            "secId": "s0010",
            "sentence": "For example, chorioamnionitis can complicate up to one third of pregnancies with preterm labor [6].",
            "startOffset": 19822,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 31973,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The following search string was used:Another 30 articles related to chorioamnionitis and vaccine were found of which 7 were excluded due to study type.",
            "startOffset": 31585,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 60221,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0095",
            "sentence": "Pregnancy history (i.e. history of or recent preterm labor, preterm premature rupture of membranes, need for cervical cerclage placement or other obstetric procedures), in particular any condition that would increase the risk of chorioamnionitis regardless of whether immunization in pregnancy occurs.",
            "startOffset": 59920,
            "title": "Clinical and maternal immunization history"
        },
        {
            "endOffset": 70203,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "The distribution of data (as numerator and denominator data) could be analyzed in predefined increments (e.g. measured values, times), where applicable.",
            "startOffset": 70051,
            "title": "Data analysis"
        },
        {
            "endOffset": 22729,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "As well, pathology services and some laboratory assessments, such as microbiologic cultures, are often not readily accessible in all resource settings.",
            "startOffset": 22578,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 50640,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0285": {
                    "endOffset": 50639,
                    "startOffset": 50635
                }
            },
            "secId": "s0050",
            "sentence": "Criteria used for gestational age assessment within this case definition (Section 2) is based on the Brighton Collaboration gestational age assessment algorithm [57].",
            "startOffset": 50474,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 69571,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "In the case of chorioamnionitis the end of episode may include childbirth or termination of pregnancy with removal of placenta and membranes either during the third stage of labor or via procedure.",
            "startOffset": 69374,
            "title": "Data analysis"
        },
        {
            "endOffset": 40066,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0225": {
                    "endOffset": 40065,
                    "startOffset": 40061
                }
            },
            "secId": "s0040",
            "sentence": "One study found that 20\u201380% of chorioamnionitis cases had maternal tachycardia, while 40\u201370% had fetal tachycardia [45].",
            "startOffset": 39946,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 54350,
            "parents": [],
            "secId": "s0065",
            "sentence": "Chorioamnionitis via histopathology or culture (See Section 1.3.5)",
            "startOffset": 54284,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 27123,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 27122,
                    "startOffset": 27115
                },
                "b0175": {
                    "endOffset": 27122,
                    "startOffset": 27115
                }
            },
            "secId": "s0010",
            "sentence": "In 2015, Morgan et al published their retrospective cohort study of 7,378 women and did not find a statistically significant difference in chorioamnionitis rates between those who were and were not vaccinated during pregnancy (odds ratio [OR] 1.51, 95% CI 0.77\u2013 2.96) [33,35].",
            "startOffset": 26847,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 53669,
            "parents": [],
            "secId": "s0065",
            "sentence": "Clinical chorioamnionitis (definition A \u2013 See Section 1.3.5) with at least one measurement of maternal temperature \u2265 38 degrees Celsius.",
            "startOffset": 53533,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 54031,
            "parents": [],
            "secId": "s0065",
            "sentence": "Confirmation via histopathology or culture (See Section 1.3.5)",
            "startOffset": 53969,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 18822,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Placental inflammation is often clinically silent and can signal the normal physiologic process of parturition, an inflammatory process, but can also be a sign of sub-clinical infection.",
            "startOffset": 18636,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 36596,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Describes evidence of intrauterine infection within 42 days of a live birth or stillbirth.",
            "startOffset": 36506,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 69743,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "It must be noted that histologic or culture-positive chorioamnionitis is often diagnosed retrospectively after childbirth or termination of pregnancy has already occurred.",
            "startOffset": 69572,
            "title": "Data analysis"
        },
        {
            "endOffset": 41672,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "In this workshop summary, suspected intraamniotic infection (labeled \u201cTriple I\u201d) was defined as maternal fever without a clear source plus one of the following: baseline fetal tachycardia, maternal leukocytosis in the absence of corticosteroids or definite purulent fluid from the cervical os.",
            "startOffset": 41379,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 52118,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0055",
            "sentence": "Neither case definition nor guidelines are intended to guide or establish criteria for clinical management.",
            "startOffset": 52011,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 69941,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "If more than one measurement of a particular criterion is taken and recorded, the value corresponding to the greatest magnitude of the adverse experience could be used as the basis for analysis.",
            "startOffset": 69747,
            "title": "Data analysis"
        },
        {
            "endOffset": 23945,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Our case definition does not include these entities.",
            "startOffset": 23893,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 63909,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Exposures other than the immunization 24 h before and after immunization (e.g. food, environmental, alternative therapies or tonics) considered potentially relevant to the reported event.",
            "startOffset": 63722,
            "title": "The adverse event"
        },
        {
            "endOffset": 72829,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "It is essential to specify:",
            "startOffset": 72802,
            "title": "Data presentation"
        },
        {
            "endOffset": 44656,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "In one study, women with acute intra-amniotic infection were found to have higher rates of high-virulence isolates compared to controls.",
            "startOffset": 44520,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 54875,
            "parents": [],
            "secId": "s0065",
            "sentence": "Chorioamnionitis via histopathology or culture (See Section 1.3.5)",
            "startOffset": 54809,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 57780,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0075",
            "sentence": "The additional guidelines have been developed as guidance for the collection of additional information to allow for a more comprehensive understanding of chorioamnionitis following immunization.",
            "startOffset": 57586,
            "title": "Data collection"
        },
        {
            "endOffset": 23892,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 23891,
                    "startOffset": 23887
                }
            },
            "secId": "s0010",
            "sentence": "Subclinical chorioamnionitis and non-infectious inflammation are within the spectrum of chorioamnionitis described in the literature and likely contribute to discrepancies found between clinical, culture-based and histologic chorioamnionitis (2) [27].",
            "startOffset": 23641,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 47961,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Maternal WBC \u2265 15,000 per mm3 in the absence of corticosteroids.",
            "startOffset": 47897,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 38343,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "In this way it is hoped that all possible cases of chorioamnionitis can be captured.",
            "startOffset": 38259,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 62659,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Concurrent signs, symptoms, and diseases.",
            "startOffset": 62618,
            "title": "The adverse event"
        },
        {
            "endOffset": 34274,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Related terms of chorioamnionitis that are not included in this case definition therefore are:",
            "startOffset": 34180,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 51243,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Therefore, to avoid selection bias, a restrictive time interval from immunization to onset of chorioamnionitis should not be an integral part of such a definition.",
            "startOffset": 51080,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 55115,
            "parents": [],
            "secId": "s0065",
            "sentence": "Clinical chorioamnionitis (definition A or B \u2013 See Section 1.3.5) with report of fever or maternal feeling of \u201cfeverishness.\u201d",
            "startOffset": 54990,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 45865,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "A treatment response or its failure is not in itself diagnostic, and may depend on variables such as clinical status, comorbidities, antenatal and intrapartum factors, and other clinical parameters.",
            "startOffset": 45667,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 60615,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose (e.g. 0.25 mL, 0.5 mL, etc) and number of dose if part of a series of immunizations against the same disease).",
            "startOffset": 60430,
            "title": "Details of the maternal immunization"
        },
        {
            "endOffset": 22280,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Unfortunately, histologic examination of the placenta may not be performed if chorioamnionitis is not suspected clinically, and, as such, many studies of chorioamnionitis have not been able to test the specificity of histologic chorioamnionitis.",
            "startOffset": 22035,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 31584,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Results were limited to English and the preceding 10 year period.",
            "startOffset": 31519,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 34359,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Fetal inflammatory response syndrome",
            "startOffset": 34323,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 60426,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "Date, time and place (city/region) of immunization(s).",
            "startOffset": 60372,
            "title": "Details of the maternal immunization"
        },
        {
            "endOffset": 67428,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Additional categories for analysis",
            "startOffset": 67394,
            "title": "Data analysis"
        },
        {
            "endOffset": 59720,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0095",
            "sentence": "(e.g. immunoglobulins, blood transfusion and immunosuppressants such as steroids given to accelerate lung maturity).",
            "startOffset": 59604,
            "title": "Clinical and maternal immunization history"
        },
        {
            "endOffset": 33388,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "Positive amniotic fluid culture or an elevated amniotic fluid white blood cell count can be referred to as microbial invasion of the amniotic cavity (MIAC) and intraamniotic inflammation, respectively, which are also within the spectrum of chorioamnionitis.",
            "startOffset": 33131,
            "title": "The term chorioamnionitis"
        },
        {
            "endOffset": 50311,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "In addition, the majority of chorioamnionitis cases occur in the context of preterm labor, prelabor rupture of membranes or prolonged labor at term.",
            "startOffset": 50163,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 60922,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "Route and method of administration (e.g. intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 60771,
            "title": "Details of the maternal immunization"
        },
        {
            "endOffset": 71627,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Data on possible chorioamnionitis events should be presented in accordance with data collection guidelines 1\u201325 and data analysis guidelines 32\u201337.",
            "startOffset": 71480,
            "title": "Data presentation"
        },
        {
            "endOffset": 72341,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g. manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population-based data, etc.).",
            "startOffset": 72114,
            "title": "Data presentation"
        },
        {
            "endOffset": 39945,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0010": {
                    "endOffset": 39944,
                    "startOffset": 39941
                }
            },
            "secId": "s0040",
            "sentence": "Chorioamnionitis is also highly associated with maternal tachycardia with heartrate (HR) greater than 100 beats per minute and fetal tachycardia with fetal heartrate (FHR) greater than 160 beats per minute [2].",
            "startOffset": 39735,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 32306,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "In addition, we conducted a grey literature search identifying latest edition text books in common usage in obstetrics and gynecology and national obstetrics and gynecology guidelines: 14 documents were added to the study/documents to review.",
            "startOffset": 32064,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 35610,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Septic abortion (add reference for Rouse C, Gravett M et al)",
            "startOffset": 35550,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 49701,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Positive culture of placental membranes (between chorion/amnion)",
            "startOffset": 49637,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 57585,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0075",
            "sentence": "These data elements include an identifiable reporter and patient, one or more prior immunizations, and a detailed description of the adverse event, in this case, of chorioamnionitis following immunization.",
            "startOffset": 57380,
            "title": "Data collection"
        },
        {
            "endOffset": 25747,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Four studies are important in the discussion of vaccinations during pregnancy and chorioamnionitis.",
            "startOffset": 25648,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 27816,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 27815,
                    "startOffset": 27811
                }
            },
            "secId": "s0010",
            "sentence": "The diagnosis of chorioamnionitis in this study was based on clinical findings only; neither culture nor histopathologic findings were included for diagnostic purposes [36].",
            "startOffset": 27643,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 48007,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Definite purulent fluid from the cervical os.",
            "startOffset": 47962,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 67286,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Level 2: Criteria as specified in the chorioamnionitis case definition",
            "startOffset": 67216,
            "title": "Data analysis"
        },
        {
            "endOffset": 69272,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "The occurrence of a possible chorioamnionitis case could be analyzed as the interval between the date/time of onset (See Footnote 12) of the first symptoms and/or signs consistent with the definition and the end of episode (See Footnote 16) and/or final outcome (see Footnote 17).",
            "startOffset": 68992,
            "title": "Data analysis"
        },
        {
            "endOffset": 55379,
            "parents": [],
            "secId": "s0065",
            "sentence": "Gestational age \u2265 22\u20130/7 weeks by any GAIA gestational age criteria (Annex 1)",
            "startOffset": 55302,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 56355,
            "parents": [],
            "secId": "s0070",
            "sentence": "Also, as explained in more detail in the overview paper in this volume, these guidelines have been developed by this working group for guidance only and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 56106,
            "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
        },
        {
            "endOffset": 45454,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0275": {
                    "endOffset": 45453,
                    "startOffset": 45449
                }
            },
            "secId": "s0040",
            "sentence": "Nucleic amplification tests such as polymerase chain reaction (PCR) for detection of intraamniotic infection is used mainly for research purposes [55].",
            "startOffset": 45303,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 63718,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Objective clinical evidence supporting classification of the event as \u201cserious\u201d19.",
            "startOffset": 63225,
            "title": "The adverse event"
        },
        {
            "endOffset": 31366,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Six committee members (AK, NC, CW, FV, AB, LE) reviewed the search results for appropriateness to the topic via both title/abstract and full text screening, resulting in 194 included documents.",
            "startOffset": 31173,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 21182,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 21181,
                    "startOffset": 21174
                },
                "b0085": {
                    "endOffset": 21181,
                    "startOffset": 21174
                }
            },
            "secId": "s0010",
            "sentence": "Severe maternal sequelae of chorioamnionitis can include puerperal sepsis which is an important cause of global maternal mortality both in low- and high-resource settings [16,17].",
            "startOffset": 21003,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 23076,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Variations in the diagnostic criteria used for chorioamnionitis in the literature make it difficult to interpret individual study results and compare data across studies.",
            "startOffset": 22906,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 42324,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0010": {
                    "endOffset": 42323,
                    "startOffset": 42320
                }
            },
            "secId": "s0040",
            "sentence": "It must be considered that maternal leukocytosis is relatively non-specific and can be induced by several factors including antenatal corticosteroids [2].",
            "startOffset": 42170,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 31085,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "This left a total of 6955 unique citations found in all searches.",
            "startOffset": 31020,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 40478,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Other, more subjective, criteria for chorioamnionitis include uterine tenderness and purulent fluid coming from the cervical os.",
            "startOffset": 40350,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 60368,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 60262,
            "title": "Details of the maternal immunization"
        },
        {
            "endOffset": 30539,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "To guide the decision-making for the case definition and guidelines, a comprehensive literature search was performed by academic library services using Pubmed, Embase and Web of Science.",
            "startOffset": 30353,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 28950,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Each study used varying definitions for chorioamnionitis including ICD-9 codes and clinical symptoms.",
            "startOffset": 28849,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 49557,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 49555,
                    "startOffset": 49545
                },
                "b0260": {
                    "endOffset": 49555,
                    "startOffset": 49545
                },
                "b0265": {
                    "endOffset": 49555,
                    "startOffset": 49545
                }
            },
            "secId": "s0045",
            "sentence": "Positive finding of invasion of maternal polymorphonuclear leukocytes into the placental plate, the chorion and/or amnion which meets criteria based on a widely accepted histopathologic staging and grading system [such as Redline, Salafia, or Blanc criteria [24,52,53]].",
            "startOffset": 49287,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 52721,
            "parents": [],
            "secId": "s0065",
            "sentence": "For all levels of diagnostic certainty",
            "startOffset": 52683,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 27349,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 27348,
                    "startOffset": 27344
                }
            },
            "secId": "s0010",
            "sentence": "The study data was taken from an institutional database of prospectively maintained pregnancy, birth and neonatal records and it is therefore unclear what diagnostic criteria for chorioamnionitis were used in this study [35].",
            "startOffset": 27124,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 57967,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "For all cases and/or all study participants (including the pregnant woman and/or neonate, as appropriate), the following information should be recorded:",
            "startOffset": 57815,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 66243,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 66136,
            "title": "Data analysis"
        },
        {
            "endOffset": 39735,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Given potentially confounding antepartum and intrapartum factors, it is considered prudent to confirm maternal fever after one finding of elevated temperature.",
            "startOffset": 39576,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 40822,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0225": {
                    "endOffset": 40821,
                    "startOffset": 40817
                }
            },
            "secId": "s0040",
            "sentence": "Uterine tenderness and purulent fluid from the cervical os were found in 4% to 25% and 5% to 22% of chorioamnionitis cases, respectively [45].",
            "startOffset": 40680,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 18635,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Signs and symptoms depend on whether a primary inflammatory versus an infectious process is found.",
            "startOffset": 18537,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 37168,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Thus, a clinically severe event may appropriately be classified as Level 2 or 3 rather than Level 1 if it could reasonably be of non-chorioamnionitis etiology.",
            "startOffset": 37009,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 42048,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Maternal leukocytosis is the laboratory finding most commonly used in the diagnosis of clinical chorioamnionitis.",
            "startOffset": 41935,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 56619,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0075",
            "sentence": "These guidelines represent a desirable standard for the collection of data on availability following immunization to allow for comparability of data and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 56373,
            "title": "Data collection"
        },
        {
            "endOffset": 46719,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Neither is considered superior; however, Clinical Definition A is more specific while Clinical Definition B is more sensitive.",
            "startOffset": 46593,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 36505,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Postpartum endometritis (add reference for Rouse C, Gravett M et al)",
            "startOffset": 36437,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 52169,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0055",
            "sentence": "Both were developed to improve data comparability.",
            "startOffset": 52119,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 53385,
            "parents": [],
            "secId": "s0065",
            "sentence": "Level 3 diagnostic certainty for gestational age has a lower accuracy compared to levels 1\u20132.",
            "startOffset": 53292,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 72918,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "The method, frequency and duration of monitoring for chorioamnionitis;",
            "startOffset": 72848,
            "title": "Data presentation"
        },
        {
            "endOffset": 45302,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 45301,
                    "startOffset": 45295
                },
                "b0270": {
                    "endOffset": 45301,
                    "startOffset": 45295
                }
            },
            "secId": "s0040",
            "sentence": "Other tests on amniotic fluid, including glucose level, lactate dehydrogenase activity, white blood cell count, and gram stain, are less reliable in identifying and confirming chorioamnionitis [1,54].",
            "startOffset": 45102,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 61351,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Clinical description of signs and symptoms of chorioamnionitis, and if there was medical confirmation of the event (i.e. patient seen by physician or skilled birth attendant).",
            "startOffset": 61176,
            "title": "The adverse event"
        },
        {
            "endOffset": 21687,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0095": {
                    "endOffset": 21686,
                    "startOffset": 21679
                },
                "b0100": {
                    "endOffset": 21686,
                    "startOffset": 21679
                }
            },
            "secId": "s0010",
            "sentence": "With regards to long-term neonatal outcomes, chorioamnionitis is associated with bronchopulmonary dysplasia, periventricular leukomalacia, and cerebral palsy [19,20].",
            "startOffset": 21521,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 46427,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Based on the discussion in Section 1.3.4, currently available definitions (see Fig. 3) are summarized here for the purpose of developing the chorioamnionitis case definition (See Fig. 3 and Section 2).",
            "startOffset": 46226,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 72801,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Any publication of data on chorioamnionitis should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 72654,
            "title": "Data presentation"
        },
        {
            "endOffset": 68643,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Examples of increments that could be used for data analysis are as follows:",
            "startOffset": 68568,
            "title": "Data analysis"
        },
        {
            "endOffset": 22034,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 22033,
                    "startOffset": 22026
                },
                "b0110": {
                    "endOffset": 22033,
                    "startOffset": 22026
                },
                "b0115": {
                    "endOffset": 22033,
                    "startOffset": 22026
                },
                "b0120": {
                    "endOffset": 22033,
                    "startOffset": 22026
                }
            },
            "secId": "s0010",
            "sentence": "The presence of inflammation and/or microbes in the placenta, amnion, chorion or amniotic fluid is considered the gold standard for diagnosis, regardless of clinical findings [21\u201324].",
            "startOffset": 21851,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 49796,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Timing considerations diagnosis of chorioamnionitis are important.",
            "startOffset": 49730,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 55196,
            "parents": [],
            "secId": "s0065",
            "sentence": "Gestational age \u2265 22\u20130/7 weeks by any GAIA gestational age criteria (Annex 1)",
            "startOffset": 55119,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 73705,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Whether the date of onset (see footnote 13) and/or the date of first observation (see footnote 14) and/or the date of diagnosis (see footnote 15) was used for analysis; and",
            "startOffset": 73533,
            "title": "Data presentation"
        },
        {
            "endOffset": 19821,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0010": {
                    "endOffset": 19820,
                    "startOffset": 19817
                },
                "b0020": {
                    "endOffset": 19736,
                    "startOffset": 19731
                },
                "b0025": {
                    "endOffset": 19736,
                    "startOffset": 19731
                }
            },
            "secId": "s0010",
            "sentence": "Chorioamnionitis or intra-amniotic infection complicates around 1\u20135% of deliveries at term [4,5]; however, estimates can vary based on diagnostic criteria used and risk factors [2].",
            "startOffset": 19640,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 43381,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "The diagnosis of histologic chorioamnionitis is performed retrospectively following childbirth.",
            "startOffset": 43286,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 31518,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "A separate search was done to identify any reports associating chorioamnionitis with vaccinations, using MEDLINE and Embase via the Embase.com platform.",
            "startOffset": 31366,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 37527,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Detailed information about the severity of the event should always be recorded, as specified by the data collection guidelines.",
            "startOffset": 37400,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 51079,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "We postulate that a definition designed to be a suitable tool for testing causal relationships requires ascertainment of the outcome (e.g. chorioamnionitis) independent from the exposure (e.g. immunizations).",
            "startOffset": 50871,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 59016,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0095",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 58910,
            "title": "Clinical and maternal immunization history"
        },
        {
            "endOffset": 20259,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 20258,
                    "startOffset": 20255
                }
            },
            "secId": "s0010",
            "sentence": "Intrauterine infection can also be transmitted via hematogenous spread as in the case of Listeria monocytogenes, or as an iatrogenic infection via procedures for prenatal diagnosis or fetal therapy [4].",
            "startOffset": 20057,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 73307,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "The search strategy in surveillance databases;",
            "startOffset": 73261,
            "title": "Data presentation"
        },
        {
            "endOffset": 21520,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 21519,
                    "startOffset": 21515
                }
            },
            "secId": "s0010",
            "sentence": "Preterm neonates are at higher risk for complications than term neonates [15].",
            "startOffset": 21442,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 28296,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The limitations of these studies include that they were all retrospective with risk for various biases.",
            "startOffset": 28193,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 68487,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "refoffsets": {
                "b0305": {
                    "endOffset": 68486,
                    "startOffset": 68482
                }
            },
            "secId": "s0115",
            "sentence": "The time-dependent nature of exposure to vaccination within pregnancy, time-dependent increased risk of events as pregnancy progresses and potential bias such as variable opportunity for vaccination in pregnancy must be considered [61].",
            "startOffset": 68251,
            "title": "Data analysis"
        },
        {
            "endOffset": 58266,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Name and contact information of person reporting13 and/or diagnosing chorioamnionitis as specified by country-specific data protection law.",
            "startOffset": 57988,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 50871,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Chorioamnionitis is diagnosed either prior to childbirth or termination of pregnancy with removal of placenta and membranes or it is diagnosed retrospectively after delivery via pathology examination of the placenta and membranes.",
            "startOffset": 50641,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 48488,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Maternal tachycardia (HR > 100 bpm)",
            "startOffset": 48453,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 49629,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Positive culture of amniotic fluid (via amniocentesis)",
            "startOffset": 49575,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 56950,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0075",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition (see above), which are not repeated in these guidelines.",
            "startOffset": 56746,
            "title": "Data collection"
        },
        {
            "endOffset": 26847,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The positive predictive value of a case with ICD-9 code of chorioamnionitis also having \u201cprobable\u201d chorioamnionitis (defined as clinical signs of chorioamnionitis with confirmatory histologic chorioamnionitis) was 0.50 (95% CI, 0.43\u20130.57), and, of note, 95% of women with an ICD-9 code for chorioamnionitis also had an epidural which can be associated with maternal fever.",
            "startOffset": 26475,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 22418,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Laboratory tests, such as amniotic fluid culture and glucose analysis, may be limited by exclusion of amniocentesis as a diagnostic test.",
            "startOffset": 22281,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 58812,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0090",
            "sentence": "Date of birth, age, and sex.",
            "startOffset": 58784,
            "title": "Demographics"
        },
        {
            "endOffset": 32975,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "Alternative terminology for chorioamnionitis includes intra-amniotic infection and amnionitis.",
            "startOffset": 32881,
            "title": "The term chorioamnionitis"
        },
        {
            "endOffset": 71840,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Terms to describe chorioamnionitis such as \u201clow-grade\u201d, \u201cmild\u201d, \u201cmoderate\u201d, \u201chigh\u201d, \u201csevere\u201d or \u201csignificant\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 71631,
            "title": "Data presentation"
        },
        {
            "endOffset": 73260,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "The characteristics of the surveillance system (e.g. population served, mode of report solicitation);",
            "startOffset": 73159,
            "title": "Data presentation"
        },
        {
            "endOffset": 42169,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 42168,
                    "startOffset": 42162
                },
                "b0125": {
                    "endOffset": 42168,
                    "startOffset": 42162
                }
            },
            "secId": "s0040",
            "sentence": "A white blood cell (WBC) count of greater or equal to 15,000/mm3 has been used as the cut-off for this criterion [1,25].",
            "startOffset": 42049,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 58781,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0090",
            "sentence": "Case/study participant identifiers (e.g. first name initial followed by last name initial) or code (or in accordance with country-specific data protection laws).",
            "startOffset": 58620,
            "title": "Demographics"
        },
        {
            "endOffset": 52010,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0290": {
                    "endOffset": 51835,
                    "startOffset": 51831
                }
            },
            "secId": "s0055",
            "sentence": "As mentioned in the overview paper [58], the case definition is accompanied by guidelines which are structured according to the steps of conducting a clinical trial, i.e. data collection, analysis and presentation.",
            "startOffset": 51796,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 33130,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "In the clinical setting with positive clinical signs and symptoms, chorioamnionitis is often referred to as \u201cclinical chorioamnionitis\u201d in the literature.",
            "startOffset": 32976,
            "title": "The term chorioamnionitis"
        },
        {
            "endOffset": 74443,
            "parents": [],
            "secId": "s0125",
            "sentence": "Specifically, the findings and conclusions in this paper are those of the authors and do not necessarily represent the views of their respective institutions.",
            "startOffset": 74285,
            "title": "Disclaimer"
        },
        {
            "endOffset": 37008,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "It needs to be emphasized that the grading of definition levels for this case definition is entirely about diagnostic certainty and does not reflect clinical severity of an event.",
            "startOffset": 36829,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 53735,
            "parents": [],
            "secId": "s0065",
            "sentence": "Confirmation via histopathology or culture (See Section 1.3.5)",
            "startOffset": 53673,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 23371,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 23370,
                    "startOffset": 23366
                }
            },
            "secId": "s0010",
            "sentence": "Diagnostic criteria for clinical chorioamnionitis are based on early work by Gibbs and colleagues who described chorioamnionitis as maternal fever with two of the following: maternal tachycardia, fetal tachycardia, uterine tenderness, foul odor of amniotic fluid, or maternal leukocytosis [25].",
            "startOffset": 23077,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 34639,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 34638,
                    "startOffset": 34634
                }
            },
            "secId": "s0030",
            "sentence": "Findings of acute histologic chorioamnionitis with placental invasion of polymorphonuclear cells but without evidence of intraamniotic infection (i.e. negative culture or negative clinical chorioamnionitis) [26].",
            "startOffset": 34427,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 67359,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Level 3: Criteria as specified in the chorioamnionitis case definition",
            "startOffset": 67289,
            "title": "Data analysis"
        },
        {
            "endOffset": 72650,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 72585,
            "title": "Data presentation"
        },
        {
            "endOffset": 20056,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 20055,
                    "startOffset": 20050
                },
                "b0035": {
                    "endOffset": 20055,
                    "startOffset": 20050
                }
            },
            "secId": "s0010",
            "sentence": "The pathogenesis of intra-amniotic infections is most commonly due to ascending infections into the placenta and chorion-amnion [4,7].",
            "startOffset": 19922,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 31172,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The complete strategy for each of the searches can be found in a separate publication.",
            "startOffset": 31086,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 68250,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Not a case of chorioamnionitis22 (33) The interval between maternal immunization and reported chorioamnionitis could be defined as the date/time of immunization during pregnancy to the date/time of onset (See Footnote 13) of the first symptoms and/or signs consistent with the definition.",
            "startOffset": 67727,
            "title": "Data analysis"
        },
        {
            "endOffset": 38258,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "As maximum specificity normally implies a loss of sensitivity, two additional diagnostic levels have been included in the definition, offering a stepwise increase of sensitivity from Level 1 down to Level 3, while retaining an acceptable level of specificity at all levels.",
            "startOffset": 37985,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 59603,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/Control"
                }
            ],
            "secId": "s0095",
            "sentence": "Any medication history (other than treatment for the event described) prior to, during, and after immunization including prescription and non-prescription medication as well as medication or treatment with long half-life or long-term effect.",
            "startOffset": 59362,
            "title": "Clinical and maternal immunization history"
        },
        {
            "endOffset": 52935,
            "parents": [],
            "secId": "s0065",
            "sentence": "See Fig. 4.",
            "startOffset": 52924,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 25167,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 25166,
                    "startOffset": 25162
                }
            },
            "secId": "s0010",
            "sentence": "The American College of Obstetricians and Gynecologists defines chorioamnionitis as \u201can infection with resultant inflammation of any combination of the amniotic fluid, placenta, fetus, fetal membranes, or decidua\u201d [32].",
            "startOffset": 24948,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 33898,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 33897,
                    "startOffset": 33894
                }
            },
            "secId": "s0025",
            "sentence": "More recently the term \u201ctriple I\u201d was coined in 2016 by an expert panel workshop at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in the United States to emphasize the full spectrum of the disease as \u201cintrauterine inflammation or infection or both\u201d, however this term is not in wide-spread use within the United States or internationally [1].",
            "startOffset": 33510,
            "title": "The term chorioamnionitis"
        },
        {
            "endOffset": 26474,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Of cases with ICD-9 codes for chorioamnionitis that were randomly selected for chart review, 19.6% of placentas were positive for histologic chorioamnionitis, while 72.3% of placentas did not have a histologic exam.",
            "startOffset": 26259,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 21002,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 21001,
                    "startOffset": 20994
                },
                "b0070": {
                    "endOffset": 21001,
                    "startOffset": 20994
                },
                "b0075": {
                    "endOffset": 21001,
                    "startOffset": 20994
                }
            },
            "secId": "s0010",
            "sentence": "Women with chorioamnionitis are at higher risk for cesarean section, need for blood transfusion, uterine atony, pelvic abscesses, postpartum endometritis and intensive care unit (ICU) admissions [13\u201315].",
            "startOffset": 20799,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 24947,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 24946,
                    "startOffset": 24942
                }
            },
            "secId": "s0010",
            "sentence": "The United Kingdom\u2019s National Institute for Health and Care Excellence (NICE) guidelines for preterm labor does not mention \u201cchorioamnionitis\u201d but does describe prelabor rupture of membranes as risk factor for \u201cintrauterine infection\u201d [31].",
            "startOffset": 24707,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 37777,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "In addition, while a case may not meet the chorioamnionitis case definition diagnostic criteria, the individual woman may still require medical attention and should undergo a thorough medical evaluation or be directed to the nearest health facility.",
            "startOffset": 37528,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 53826,
            "parents": [],
            "secId": "s0065",
            "sentence": "Gestational age \u2265 22\u20130/7 weeks by GAIA gestational age level 1\u20132 criteria (See Annex 1)",
            "startOffset": 53739,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 30828,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The search terms for MEDLINE via PubMed is shown below and was modified for Embase and Web of Science search terminology (see Table 1).",
            "startOffset": 30693,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 34769,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 34768,
                    "startOffset": 34765
                }
            },
            "secId": "s0030",
            "sentence": "Term coined by the NICHD workshop expert panel to better describe \u201cintrauterine inflammation or infection or both\u201d [1].",
            "startOffset": 34650,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 43883,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 43882,
                    "startOffset": 43872
                },
                "b0260": {
                    "endOffset": 43882,
                    "startOffset": 43872
                },
                "b0265": {
                    "endOffset": 43882,
                    "startOffset": 43872
                }
            },
            "secId": "s0040",
            "sentence": "There are various staging and grading criteria that have been used in the literature regarding pathologic findings of chorioamnionitis within the placenta and membranes and include Redline, Salafia, and Blanc criteria [24,52,53].",
            "startOffset": 43654,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 44942,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Other routes of infection described include hematogenous spread of bacteria such as Listeria monocytogenes, group A streptococci and Campylobacter spp.",
            "startOffset": 44791,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 22577,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Even if an amniotic fluid culture is obtained, cultures of certain pathogens such as Ureaplasma urealyticum are difficult to perform and not widely available.",
            "startOffset": 22419,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 35231,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 35230,
                    "startOffset": 35226
                }
            },
            "secId": "s0030",
            "sentence": "Funisitis is the histologic counterpart to Fetal Inflammatory Response Syndrome [27].",
            "startOffset": 35146,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 55764,
            "parents": [],
            "secId": "s0070",
            "sentence": "It was the consensus of the Brighton Collaboration Chorioamnionitis Working Group to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about chorioamnionitis.",
            "startOffset": 55529,
            "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
        },
        {
            "endOffset": 50473,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0280": {
                    "endOffset": 50472,
                    "startOffset": 50468
                }
            },
            "secId": "s0050",
            "sentence": "This gestational age is based on the Brighton Collaboration spontaneous abortion and ectopic pregnancy guidelines and may not be applicable in all settings [56].",
            "startOffset": 50312,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 67394,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Event does not meet case definition",
            "startOffset": 67359,
            "title": "Data analysis"
        },
        {
            "endOffset": 21441,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 21440,
                    "startOffset": 21430
                },
                "b0075": {
                    "endOffset": 21440,
                    "startOffset": 21430
                },
                "b0090": {
                    "endOffset": 21440,
                    "startOffset": 21430
                }
            },
            "secId": "s0010",
            "sentence": "Fetal and immediate neonatal consequences of chorioamnionitis include neonatal depression at birth, neonatal sepsis, need for mechanical ventilation, intraventricular hemorrhage, fetal inflammatory response syndrome (FIRS), and neonatal mortality [14,15,18].",
            "startOffset": 21183,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 72455,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 72345,
            "title": "Data presentation"
        },
        {
            "endOffset": 24060,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There are a variety of definitions for chorioamnionitis set forth by international and national health authorities.",
            "startOffset": 23945,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 54143,
            "parents": [],
            "secId": "s0065",
            "sentence": "Level 2 of diagnostic certainty",
            "startOffset": 54112,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 54437,
            "parents": [],
            "secId": "s0065",
            "sentence": "Gestational age \u2265 22\u20130/7 weeks by GAIA gestational age level 1\u20132 criteria (Annex 1)",
            "startOffset": 54354,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 25488,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "With regards to vaccine research, there are several studies that have investigated maternal immunizations and associations with adverse pregnancy outcomes such as chorioamnionitis.",
            "startOffset": 25308,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 47227,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0045",
            "sentence": "Maternal fever \u2265 38 degrees Celsius on one occasion.4",
            "startOffset": 47031,
            "title": "Summary of clinical, laboratory, histology and microbiology definitions used for the chorioamnionitis case definition"
        },
        {
            "endOffset": 54576,
            "parents": [],
            "secId": "s0065",
            "sentence": "Clinical chorioamnionitis (definition B \u2013 see Section 1.3.5) with at least one measurement of maternal temperature \u2265 38 degrees Celsius.",
            "startOffset": 54440,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 74144,
            "parents": [],
            "secId": "s0125",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 73988,
            "title": "Disclaimer"
        },
        {
            "endOffset": 54282,
            "parents": [],
            "secId": "s0065",
            "sentence": "Clinical chorioamnionitis (definition A \u2013 See Section 1.3.5) with at least one measurement of maternal temperature \u2265 38 degrees Celsius.",
            "startOffset": 54146,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 40679,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Purulent fluid coming from the os depends on a speculum examination.",
            "startOffset": 40611,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 65992,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Reported events should be classified in one of the following five categories including the three levels of diagnostic certainty.",
            "startOffset": 65864,
            "title": "Data analysis"
        },
        {
            "endOffset": 35145,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Presence of polymorphonuclear cells in fetal structures including the umbilical cord (i.e. the umbilical vessels and/or Wharton\u2019s jelly).",
            "startOffset": 35008,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 38587,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Based on our literature review, factors important for the diagnosis of chorioamnionitis include clinical, laboratory and microbiology, and pathology findings.",
            "startOffset": 38429,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 67140,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0115",
            "sentence": "Event meets case definition",
            "startOffset": 67113,
            "title": "Data analysis"
        },
        {
            "endOffset": 43285,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 43284,
                    "startOffset": 43280
                }
            },
            "secId": "s0040",
            "sentence": "In addition, histologic chorioamnionitis in term, low-risk pregnancies is often associated with placental inflammation rather than placental infection [26].",
            "startOffset": 43129,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 20798,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Clinically, intra-amnionitic infections can cause significant maternal, fetal and neonatal morbidity and mortality.",
            "startOffset": 20683,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 43973,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Redline criteria for diagnosis of histologic chorioamnionitis are outlined in Appendix B.",
            "startOffset": 43884,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 41914,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 41913,
                    "startOffset": 41910
                }
            },
            "secId": "s0040",
            "sentence": "Confirmed intraamniotic infection (or \u201cTriple I\u201d) was diagnosed with amniocentesis-proven positive gram stain, low amniotic fluid glucose or positive amniotic fluid culture or with placental pathologic features consistent with infection [1].",
            "startOffset": 41673,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 43653,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0255": {
                    "endOffset": 43621,
                    "startOffset": 43617
                }
            },
            "secId": "s0040",
            "sentence": "The diagnostic criteria are based on the stage and grade of maternal polymorphonuclear leukocyte invasion per high-power field into the placental plate and into the membranes, from the chorion to the amnion in an amniotropic direction [51] (see placental anatomy Fig. 1).",
            "startOffset": 43382,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 54663,
            "parents": [],
            "secId": "s0065",
            "sentence": "Gestational age \u2265 22\u20130/7 weeks by GAIA gestational age level 1\u20132 criteria (Annex 1)",
            "startOffset": 54580,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 71361,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "refoffsets": {
                "b0310": {
                    "endOffset": 71360,
                    "startOffset": 71353
                },
                "b0315": {
                    "endOffset": 71360,
                    "startOffset": 71353
                },
                "b0320": {
                    "endOffset": 71360,
                    "startOffset": 71353
                }
            },
            "secId": "s0120",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomized controlled trials, systematic reviews, and meta-analyses of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of Improving the quality of reports of meta-analyses of randomized controlled trials (QUORUM), and of Meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively) [62\u201364].",
            "startOffset": 70878,
            "title": "Data presentation"
        },
        {
            "endOffset": 29158,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This prevents comparison of data across studies and underscores the necessity for a harmonized definition for chorioamnionitis in research studies.",
            "startOffset": 29011,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 53965,
            "parents": [],
            "secId": "s0065",
            "sentence": "Clinical chorioamnionitis (definition A \u2013 See Section 1.3.5) with at least one measurement of maternal temperature \u2265 38 degrees Celsius.",
            "startOffset": 53829,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 24500,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 24499,
                    "startOffset": 24495
                }
            },
            "secId": "s0010",
            "sentence": "In their guideline document, the World Health Organization (WHO) defines peripartum infections as \u201cbacterial infection of the genital tract or its surrounding tissues occurring at any time between the onset of rupture of membranes or labor and the 42nd day postpartum in which two or more of the following are present: pelvic pain, fever, abnormal vaginal discharge, abnormal smell/foul odor discharge or delay in uterine involution\u201d [28].",
            "startOffset": 24061,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 37399,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Level 1 diagnostic certainty typically incorporates gold standard diagnostic methods and has the greatest specificity for an adverse event, while Levels 2 and 3 have increasing sensitivity for a disease but decreasing specificity.",
            "startOffset": 37169,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 44790,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 44789,
                    "startOffset": 44785
                }
            },
            "secId": "s0040",
            "sentence": "These included group B streptococci, \u03b1-hemolytic streptococci, Escherichia coli, Clostridium spp, Bacteroides spp, among others [25].",
            "startOffset": 44657,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 72113,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Although immunization safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 71950,
            "title": "Data presentation"
        },
        {
            "endOffset": 73158,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "The type of surveillance (e.g. passive or active surveillance);",
            "startOffset": 73095,
            "title": "Data presentation"
        },
        {
            "endOffset": 39249,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0215": {
                    "endOffset": 39248,
                    "startOffset": 39241
                },
                "b0220": {
                    "endOffset": 39248,
                    "startOffset": 39241
                }
            },
            "secId": "s0040",
            "sentence": "Elevated maternal temperature can be caused by infectious processes such as chorioamnionitis but has also been found to be associated with non-infectious etiologies including epidural anesthesia and elevated room temperature [43,44].",
            "startOffset": 39016,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 28045,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Finally, in 2015, Datwani et al published their review of the Vaccine Adverse Event Reporting System (VAERS) database to explore reports of chorioamnionitis after receipt of any vaccine in the United States between 1990 and 2014.",
            "startOffset": 27816,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 32727,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "A flow diagram of identified sources is shown in Fig. 2.",
            "startOffset": 32671,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 36437,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Describes evidence of intrauterine infection within 42 days of a competed abortion or a non-viable pregnancy at less than 22 weeks estimated gestational age.2",
            "startOffset": 35611,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 60767,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "The anatomical sites (including left or right side) of all immunizations (e.g. vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 60619,
            "title": "Details of the maternal immunization"
        },
        {
            "endOffset": 19055,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The identification of an infectious etiology, such as a positive amniotic fluid culture, or the development of clinical findings, are indicative of a pathologic process that may progress to more severe maternal and neonatal disease.",
            "startOffset": 18823,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 25840,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In 2014, Kharbanda et al published their observational cohort study involving 123,494 women.",
            "startOffset": 25748,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 44519,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Most intra-amniotic infections are ascending in origin from the genital tract and are polymicrobial, with both anaerobic and aerobic organisms isolated.",
            "startOffset": 44367,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 73094,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation;",
            "startOffset": 72919,
            "title": "Data presentation"
        },
        {
            "endOffset": 39354,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0225": {
                    "endOffset": 39353,
                    "startOffset": 39349
                }
            },
            "secId": "s0040",
            "sentence": "Presence of maternal fever is a necessary criterion for the diagnosis of clinical chorioamnionitis [45].",
            "startOffset": 39250,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 53402,
            "parents": [],
            "secId": "s0065",
            "sentence": "(see Appendix 1)",
            "startOffset": 53386,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 18371,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 18370,
                    "startOffset": 18365
                },
                "b0010": {
                    "endOffset": 18370,
                    "startOffset": 18365
                }
            },
            "secId": "s0010",
            "sentence": "Chorioamnionitis is a term encompassing a broad spectrum of disease during pregnancy that is characterized by inflammation and/or infection of intrauterine structures such as the placenta, the chorion and amnion (see Fig. 1) [1,2].",
            "startOffset": 18140,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 71476,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "All reported events of chorioamnionitis should be presented according to the categories listed in guideline 32.",
            "startOffset": 71365,
            "title": "Data presentation"
        },
        {
            "endOffset": 28193,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 28192,
                    "startOffset": 28188
                }
            },
            "secId": "s0010",
            "sentence": "Chorioamnionitis was found to be present in 1% of pregnancy reports to VAERS and most cases had at least one risk factor for chorioamnionitis [37].",
            "startOffset": 28046,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 35550,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "It describes the fetal response as opposed to the maternal response as is seen in chorioamnionitis.",
            "startOffset": 35451,
            "title": "Related terms of chorioamnionitis and differentiation of chorioamnionitis from other (similar/associated) disorders"
        },
        {
            "endOffset": 25647,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 25646,
                    "startOffset": 25642
                }
            },
            "secId": "s0010",
            "sentence": "A recent systematic review by McMillan et al summarizes antenatal, birth and infant outcomes including chorioamnionitis following maternal immunizations [33].",
            "startOffset": 25489,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 54987,
            "parents": [],
            "secId": "s0065",
            "sentence": "Level 3 of diagnostic certainty",
            "startOffset": 54956,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 29010,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "One study did not specify how chorioamnionitis was defined.",
            "startOffset": 28951,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 32670,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "A total of 243 studies and documents, including information on a working definition for chorioamnionitis, the appropriate method of diagnosis, or any association of chorioamnionitis as a complication of vaccination, were therefore selected for review.",
            "startOffset": 32419,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for chorioamnionitis as an adverse event following immunization"
        },
        {
            "endOffset": 43128,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 43127,
                    "startOffset": 43120
                },
                "b0250": {
                    "endOffset": 43127,
                    "startOffset": 43120
                }
            },
            "secId": "s0040",
            "sentence": "Positive histologic findings have been found to be more sensitive than clinical chorioamnionitis confirmed via amniotic fluid culture [23,50].",
            "startOffset": 42986,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 57379,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "refoffsets": {
                "b0295": {
                    "endOffset": 57247,
                    "startOffset": 57243
                },
                "b0300": {
                    "endOffset": 57378,
                    "startOffset": 57374
                }
            },
            "secId": "s0075",
            "sentence": "Guidelines 1\u201344 below have been developed to address data elements for the collection of adverse event information as specified in general drug safety guidelines by the International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use [59], and the form for reporting of drug adverse events by the Council for International Organizations of Medical Sciences (CIOMS) [60].",
            "startOffset": 56950,
            "title": "Data collection"
        },
        {
            "endOffset": 73532,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of chorioamnionitis"
                }
            ],
            "secId": "s0120",
            "sentence": "Whether the day of immunization was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis;",
            "startOffset": 73445,
            "title": "Data presentation"
        },
        {
            "endOffset": 53291,
            "parents": [],
            "secId": "s0065",
            "sentence": "GAIA gestational age level 1\u20132 criteria denote higher gestational age certainty including a combination of certain last menstrual period (LMP), first or second trimester ultrasound or first trimester exam confirmation.",
            "startOffset": 53073,
            "title": "Case definition of chorioamnionitis11An event does not meet the case definition if investigation reveals a negative finding of a necessary criterion (necessary condition) for diagnosis. Such an event should be rejected and classified as \u201cNot a case of chorioamnionitis\u201d11"
        },
        {
            "endOffset": 37984,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of chorioamnionitis as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The case definition has been formulated such that the Level 1 definition is highly specific for the condition.",
            "startOffset": 37874,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        }
    ],
    "docId": "S0264410X19306541",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Alisa",
                "initial": "A.",
                "last": "Kachikis"
            },
            {
                "email": null,
                "first": "Linda O.",
                "initial": "L.O.",
                "last": "Eckert"
            },
            {
                "email": null,
                "first": "Christie",
                "initial": "C.",
                "last": "Walker"
            },
            {
                "email": null,
                "first": "Azucena",
                "initial": "A.",
                "last": "Bardaj\u00ed"
            },
            {
                "email": null,
                "first": "Frederick",
                "initial": "F.",
                "last": "Varricchio"
            },
            {
                "email": null,
                "first": "Heather S.",
                "initial": "H.S.",
                "last": "Lipkind"
            },
            {
                "email": null,
                "first": "Khady",
                "initial": "K.",
                "last": "Diouf"
            },
            {
                "email": null,
                "first": "Wan Ting",
                "initial": "W.T.",
                "last": "Huang"
            },
            {
                "email": null,
                "first": "Ronald",
                "initial": "R.",
                "last": "Mataya"
            },
            {
                "email": null,
                "first": "Mustapha",
                "initial": "M.",
                "last": "Bittaye"
            },
            {
                "email": null,
                "first": "Clare",
                "initial": "C.",
                "last": "Cutland"
            },
            {
                "email": null,
                "first": "Nansi S.",
                "initial": "N.S.",
                "last": "Boghossian"
            },
            {
                "email": null,
                "first": "Tamala",
                "initial": "T.",
                "last": "Mallett Moore"
            },
            {
                "email": null,
                "first": "Rebecca",
                "initial": "R.",
                "last": "McCall"
            },
            {
                "email": null,
                "first": "Jay",
                "initial": "J.",
                "last": "King"
            },
            {
                "email": null,
                "first": "Shuchita",
                "initial": "S.",
                "last": "Mundle"
            },
            {
                "email": null,
                "first": "Flor M.",
                "initial": "F.M.",
                "last": "Munoz"
            },
            {
                "email": null,
                "first": "Caroline",
                "initial": "C.",
                "last": "Rouse"
            },
            {
                "email": null,
                "first": "Michael",
                "initial": "M.",
                "last": "Gravett"
            },
            {
                "email": null,
                "first": "Lakshmi",
                "initial": "L.",
                "last": "Katikaneni"
            },
            {
                "email": null,
                "first": "Kevin",
                "initial": "K.",
                "last": "Ault"
            },
            {
                "email": null,
                "first": "Nicola P.",
                "initial": "N.P.",
                "last": "Klein"
            },
            {
                "email": null,
                "first": "Drucilla J.",
                "initial": "D.J.",
                "last": "Roberts"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": "secretariat@brightoncollaboration.org",
                "first": "Nancy",
                "initial": "N.",
                "last": "Chescheir"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2019.05.030",
        "firstpage": "7610",
        "issn": "0264410X",
        "keywords": [
            "Adverse event",
            "Amnionitis",
            "Case definition",
            "Chorioamnionitis",
            "Guidelines",
            "Immunization",
            "Intra-amniotic infection"
        ],
        "lastpage": "7622",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data"
    }
}